Skip to content
naulon
Get started

No retraction, correction or concern found when last checked on Oct 26, 2026.

Management strategies for the treatment and prevention of postoperative/postdischarge nausea and vomiting: an updated review

Ofelia Loani Elvir-Lazo, Paul F. White, Roya Yumul and 1 more

F1000Research · 2020 · Review

doi:10.12688/f1000research.21832.1

Abstract

Postoperative nausea and vomiting (PONV) and postdischarge nausea and vomiting (PDNV) remain common and distressing complications following surgery. The routine use of opioid analgesics for perioperative pain management is a major contributing factor to both PONV and PDNV after surgery. PONV and PDNV can delay discharge from the hospital or surgicenter, delay the return to normal activities of daily living after discharge home, and increase medical costs. The high incidence of PONV and PDNV has persisted despite the introduction of many new antiemetic drugs (and more aggressive use of antiemetic prophylaxis) over the last two decades as a result of growth in minimally invasive ambulatory surgery and the increased emphasis on earlier mobilization and discharge after both minor and major surgical procedures (e.g. enhanced recovery protocols). Pharmacologic management of PONV should be tailored to the patient’s risk level using the validated PONV and PDNV risk-scoring systems to encourage cost-effective practices and minimize the potential for adverse side effects due to drug interactions in the perioperative period. A combination of prophylactic antiemetic drugs with different mechanisms of action should be administered to patients with moderate to high risk of developing PONV. In addition to utilizing prophylactic antiemetic drugs, the management of perioperative pain using opioid-sparing multimodal analgesic techniques is critically important for achieving an enhanced recovery after surgery. In conclusion, the utilization of strategies to reduce the baseline risk of PONV (e.g. adequate hydration and the use of nonpharmacologic antiemetic and opioid-sparing analgesic techniques) and implementing multimodal antiemetic and analgesic regimens will reduce the likelihood of patients developing PONV and PDNV after surgery.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 26, 2026. Paragraph numbers are ours, so an answer can point at one.

Introduction

Nausea is an unpleasant sensation causing discomfort in the stomach area which gives the feeling of the impending need to vomit or retch. It is often a transient sensation which is frequently followed by active retching or tachycardia and increased salivation,. Vomiting is the involuntary, forceful expulsion of the contents of the stomach through the mouth and/or nose,. The incidence of these side effects varies from 30–80% after elective surgery depending on the type of anesthesia and surgery as well as predisposing patient risk factors,.

Postoperative nausea and vomiting (PONV) describes nausea and/or vomiting or retching occurring in the postanesthesia care unit (PACU) or during the first 24–48 hours after surgery. Postdischarge nausea and vomiting (PDNV) refers to symptoms that occur after discharge from the hospital or surgical care facility. Not only is PONV a distressing complication from the patient’s perspective but also it can result in dehydration, electrolyte imbalance, acid base imbalance, pulmonary aspiration, pneumothorax, hypoxia, esophageal rupture, increased intracranial pressure, suture rupture, wound dehiscence, bleeding, delay in the ability to resume oral intake, prolonged PACU and/or hospital stay, fatigue, anxiety, unanticipated hospital admission or readmission, and increased medical costs. The distressing symptoms of PONV/PDNV also contribute to patient dissatisfaction with their surgical experience –. PONV prophylaxis is economically beneficial for the hospital when a rational multimodal program is implemented based on patient and procedural risk factors,.

There have been over 4,000 peer-reviewed publications describing treatments for PONV/PDNV in the last 50 years, and numerous new antiemetic drugs and devices have been introduced into clinical practice, yet practitioners have been unable to eliminate this common postoperative problem,. The use of opioid analgesics during the perioperative period for the treatment and/or prevention of pain is a major contributing factor in patients who are at risk of developing PONV and PDNV. Dinges et al. found that, compared to morphine, the risk ratio for nausea and vomiting did not significantly differ among different opioid compounds except for a higher incidence with buprenorphine and a lower incidence with fentanyl. Despite more widespread use of combinations of prophylactic antiemetic drugs, shorter-acting anesthetic, analgesic, and muscle relaxant drugs, and multimodal analgesic regimens, PONV still affects approximately 30% of all elective surgical patients, with certain high-risk patients experiencing rates of up to 80%,,. As newer antiemetic drugs with better safety profiles are introduced into clinical practice, clinical studies are needed to determine the most cost-effective practices for controlling PONV while minimizing other side effects due to unexpected drug–drug interactions. The high incidence of PONV has persisted in part because of the tremendous growth in ambulatory surgery and the increased emphasis on earlier mobilization and discharge after both minor and major operations. One in four patients undergoing ambulatory laparoscopic surgery experienced PONV before discharge. Also, the combination of PONV and pain was present in more than 50% of this patient population. Of interest, a higher incidence of PONV was reported in patients with longer preoperative waiting times (>45 minutes). Despite the extensive literature, the optimal prophylactic antiemetic regimen for specific surgical procedures has not been established,,. This review article will focus on the most recently published peer-reviewed literature, as well as some of the classical references, considering both prevention and treatment of PONV using evidence-based multimodal antiemetic prophylaxis regimens. We will also examine pharmacological and nonpharmacological approaches.

Risk factors for PONV and PDNV

By identifying risk factors for PONV, we can ensure that those patients who are the most in need and stand to gain the greatest benefit receive optimal antiemetic prophylaxis –. A number of factors, including patient-, anesthetic-, and surgical-related factors, influence the occurence of postoperative emetic symptoms ( Table 1– Table 3),. Patient-specific factors include female gender (odds ratio [OR] 2.57), non-smoking status (OR 1.82), history of PONV or motion sickness (OR 2.09) –, and age <50 years (OR 1.79 in PACU and OR 2.17 for PDNV),,. In children, prior to puberty, female gender does not increase the risk of PONV,,. There is very limited literature regarding the risk of POV/PONV in children exposed to secondhand smoke. In children, both a prior history of PONV or postoperative vomiting (POV) and a history of PONV or POV in a parent or sibling increase their risk of POV/PONV. Chandrakantan et al. and Kocaturk et al., found that when PONV persisted into the postdischarge period, pain was often a contributing factor. Turgut et al. also reported that PONV was more common in disabled patients younger than 18 years. Younger children were at lower risk of PONV, –, while others have found no effect of age on PONV in children.

Anesthesia-related risk factors ( Table 1– Table 3) include the use of opioids, volatile agents, nitrous oxide (which increases the risk for postoperative vomiting), and high doses of neostigmine for the reversal of residual neuromuscular blockade,, –. General anesthesia is associated with a higher incidence of PONV compared with regional anesthesia,, secondary to the greater requirement for opioid medication to control postoperative pain after general anesthesia in both adults and children,. The performance of peripheral nerve blocks –, ganglion block, and wound infiltration with local anesthetic has been shown to decrease the incidence of PONV. Surgery-related predictors include prolonged surgical procedures, with each 30 minutes increasing the risk of PONV by 60%. Certain types of surgery (e.g. ophthalmic, oral, and maxillofacial surgeries, ENT surgery, neurosurgery, laparoscopy, abdominal surgeries, cholecystectomy, and gynecological surgery) have a higher incidence of PONV perhaps because of the longer exposure to general anesthesia and use of larger doses of opioid medications. In open abdominal or intra-abdominal laparoscopic surgery, post-operative ileus can occur because of gut ischemia releasing 5-HT,. Opioid use is related to a number of perioperative side effects, one of which is PONV, and they can hinder hospital discharge and return to normal activities of daily life after surgery,. Li et al. demonstrated that non-smoking female patients who exhibited a fentanyl-induced cough at anesthesia induction also had a higher likelihood of developing PONV. In a retrospective observational study, Hozumi and colleagues found a dose-dependent relationship between the dosage of remifentanil administered during surgery and an increased risk of developing PONV. Strategies to minimize the use of opioids should be considered for all patients at moderate and high risk of developing PONV. Although the notion is still controversial, some studies have suggested that the risk of PONV is higher with some opioids (e.g. morphine) than others (e.g. hydromorphone). Palumbo et al. found that compared to remifentanil, fentanyl was associated with a higher incidence of PONV after inguinal hernia repair. Tao et al. reported that the incidence of PONV in gynecological patients who underwent laparoscopic surgery was lower when using intraoperative and postoperative intravenous (IV) oxycodone compared to IV sufentanil. However, Han et al. did not find a difference in the incidence of PONV when IV oxycodone was compared to IV sufentanil in the PACU, but on the post-surgical wards a higher incidence of PONV was found in patients receiving sufentanil. The use of long-acting opioid analgesic techniques like intrathecal morphine or modified-release oral opioids not only prolongs the duration of analgesia but also can extend the duration of PONV –. In one study, naloxone was added to intrathecal morphine and significantly decreased the severity of postoperative nausea and pruritus after cesarean section.

The use of propofol for anesthesia (or sedation) is associated with a 3.5-fold reduction in the incidence of PONV in adults and 5.7-fold reduction in children. Bhakta et al. suggested that propofol-based anesthesia (e.g. total IV anesthesia [TIVA]) was associated with significantly less POV and faster recovery compared to standard “balanced” anesthesia in patients undergoing gynecological laparoscopy. Etomidate has been shown to produce an increase of PONV compared to propofol in elderly patients undergoing gastroscopy and ambulatory surgery –. Ketamine has morphine-sparing effects in lower subanesthetic dosages; however, its psychosomatic effects with high dosages during dissociative anesthesia (and sedation) have led to emergence agitation and PONV. Pan et al. found that ketamine (0.5–1.0 mg/kg intra-articular or 0.01–0.15 mg/kg IV) did not increase PONV in patients undergoing knee arthroscopy. Perioperative intravenous ketamine minimally reduced the risk of PONV (high‐quality evidence). Moro et al. compared saline to ketamine 0.2–0.4 mg/kg in patients who underwent laparoscopic cholecystectomy and found that the incidence of PONV did not differ. Controversial findings have suggested that ketamine and etomidate did not increase PONV at doses commonly administered for induction of anesthesia and that low-dose ketamine may actually reduce PONV by decreasing postoperative opioid requirements,.

A history of chemotherapy-induced nausea and vomiting (CINV) may increase the risk of PONV after surgery (OR 3.15). Psychological factors such as acute anxiety sensitivity (i.e. a fear of behaviors or sensations associated with the experience of anxiety) should be added to PONV risk-scores, and prophylaxis should be considered when patients show evidence of high anxiety sensitivity. Odom et al. found that the psychometric properties of the Ambulatory Surgery Index of Nausea, Vomiting, and Retching (AS-INVR) provided a reliable and valid measure of the amount of distress and nausea and vomiting. Ethnicity and genetic polymorphisms – could be useful in improving the predictability of PONV, which would help to improve both the prevention and the treatment of PONV. For example, CYP2D6 seems to be related to a higher incidence of PONV, especially in the first 24 hours after surgery. The ABCB1 transporter could reduce PONV owing to its association with the effectiveness of ondansetron in antiemetic prophylaxis. With regard to ethnicity, the incidence of PONV is known to be higher in non-Africans than in Africans undergoing the same surgical procedures with the same anesthetic drugs –. Interestingly, the platelet count (PLT), mean platelet volume (MPV), and MPV/PLT ratio were used to predict POV in children. The neutrophil/lymphocyte ratio (NLR) was also used to predict PONV: when the NLR was greater than 2 in patients undergoing ambulatory maxillofacial surgery, they experienced a statistically higher incidence of PONV compared to an NLR of less than 2.

Risk-scoring systems for PONV and PDNV

Antiemetics produce major side effects ranging from mild headache to severe arrhythmia due to QTc prolongation. Therefore, it is essential to calculate the risk of developing PONV and PDNV in each patient to reduce excessive use of antiemetics for prophylaxis,. Apfel et al. developed a simplified risk-scoring system for PONV in adults; the primary predictors consist of female gender, history of PONV or motion sickness, non-smoking status, and postoperative opioid use ( Table 1). The PONV risk increases by 10, 21, 39, 69, and 79% when 0, 1, 2, 3, and 4 factors are present, respectively. The use of Apfel's risk-scoring system is more sensitive and specific compared to predicting PONV based on history of PONV or type of surgery alone,.

However, the adult risk-scores are not directly applicable to children. The Eberhart classification scoring system is commonly used for children and includes the following risk factors: age >3 years, duration of surgery >30 minutes, strabismus surgery, and history of POV or a close relative with POV/PONV. The risk of POV for children undergoing strabismus surgery with 0 to 1, 2, 3, or 4 of these risk factors was 10, 30, 50, and 70%, respectively. This scoring system has also been validated for children having surgery other than for strabismus, and POV was observed in 3, 11, 30, and 40% of children who had 0, 1, 2, or 3 risk factors, respectively. A study by White et al. reported that an Apfel risk-score of 3 or 4 (versus a score of 1–2) is associated with a higher incidence of emesis in the first 24 hours after surgery irrespective of administration of multiple antiemetics as prophylaxis.

The prevention of PONV should be tailored to the patient’s risk-score to avoid side effects and unnecessary costs related to administering multiple antiemetic drugs irrespective of their risk –. The prevention of PDNV is still a problem in the ever-increasing group of outpatients having more complicated ambulatory and office-based surgical procedures,. In a multi-center study, 37% of 2,170 adult ambulatory surgery patients administered general anesthesia exhibited PDNV. Since these patients often do not have ready access to “rescue” antiemetic drug therapies after their discharge home, the use of simple nonpharmacologic antiemetic devices (e.g. acupressure) represents a low-risk and cost-effective alternative,. White et al. used the Pressure Right acupressure device in combination with antiemetic drugs to significantly reduce the incidence of vomiting from 0–72 hours after surgery with an associated improvement in patient satisfaction with their PONV management. Coloma et al. reported that the use of acustimulation with the ReliefBand can be used as an alternative to ondansetron for the treatment of established PONV. However, the use of ondansetron (4 mg IV) in combination with the ReliefBand device improved the overall response rate compared to acustimulation alone. Similar results were reported by White and colleagues. Odom-Forren et al. found that pain and postdischarge opioid use seem to be factors in late PDNV. The main difference between risk factors for PONV and PDNV was that patients who experienced nausea in the PACU had a threefold greater risk for developing PDNV. Interestingly, non-smoking status was not an independent predictor for PDNV. When 0, 1, 2, 3, 4, and 5 risk factors are present, the corresponding risk for PDNV is approximately 10, 20, 30, 50, 60, and 80%, respectively.

Perioperative antiemetic drugs used for the treatment and/or prevention of PONV

The concern with widespread prescribing of anti-vomiting drugs is primarily related to the increased costs associated with this practice, especially when expensive proprietary antiemetics are prescribed. In addition, side effects and adverse drug interactions associated with the routine use of prophylactic antiemetics is another concern (e.g. extrapyramidal effects, sedation, arrhythmias, orthostatic hypotension) –. The side effects related to the routine use of prophylactic antiemetic drugs (e.g. restlessness, dry mouth, drowsiness, headache, tachycardia, hypotension, and fatigue) can also prolong the length of stay in the surgical facility and the time to restart routine activities of daily living –.

Antiemetic drug classes

The currently available antiemetic drugs for the treatment and prevention of PONV include the 5-hydroxytryptamine (5-HT 3) receptor antagonists, neurokinin-1 (NK-1) receptor antagonists, corticosteroids, butyrophenones, metoclopramide, phenothiazine, prochlorperazine, antihistamines, and anticholinergics ( Table 4). Conventional prophylactic dosages and suggested timings for the administration of antiemetics are listed in Table 5. Apfel et al. reported that droperidol, dexamethasone, and ondansetron all carry similar antiemetic efficacy when given for prophylaxis.

5-HT 3 receptor antagonists. 5-HT 3 receptor antagonists are recommended as the first-line regimen for PONV prophylaxis. Ondansetron IV is commonly administered near the end of surgery. Multiple trials have reported that ondansetron 4 mg IV (usually administered before the end of surgery) was effective to prevent and treat PONV, facilitating both early and late recovery and improving patient satisfaction after different types of surgery (e.g. outpatient laparoscopy, laparoscopic surgery –, major surgical procedures in women, and cesarean section ). When ondansetron was administered at 8 mg, a reduction in postpartum headache up to 4 days was observed; it also reduced PONV as it did with 4 mg. Koyuncu et al. found that ondansetron 8 mg decreased the analgesic effect of acetaminophen 1 g (then 1 g every 6 hours for 24 hours) during the initial postoperative period after hysterectomy. Granisetron, a more selective 5-HT 3 antagonist, has been suggested to provide more sustained antiemesis as a prophylactic. White et al. showed that granisetron (1 mg orally) was just as effective as ondansetron (4 mg IV) for lowering the occurrence of PONV after laparoscopic procedures. Granisetron has been reported to be effective alone or in combination to treat PONV in patients undergoing laparoscopic surgery –. Ramosetron has higher affinity to the 5-HT 3 receptor and longer duration of antiemetic action, resulting in a similar or greater prophylactic antiemetic effect than the older 5-HT 3 receptor antagonists (e.g. granisetron and ondansetron) and has also been reported to provide a better prophylactic and antiemetic efficacy in patients at moderate to high risk, –.

Palonosetron is a second-generation 5-HT 3 receptor antagonist with proposed higher efficacy and more prolonged duration of action when used for antiemetic prophylaxis. Palonosetron was found to be more efficient than ondansetron or ramosetron for antiemetic prophylaxis in patients undergoing laparoscopic surgery –. However, Kim et al. failed to find a difference between palonosetron and ramosetron in patients undergoing any type of elective surgery involving general or regional anesthesia.

Glucocorticoid steroids. Dexamethasone, a corticosteroid, has been shown to be an effective antiemetic when administered at a dosage of 4–12 mg IV –. However, Ormel et al. found that dexamethasone 4–5 mg was equally as effective as 8–10 mg in terms of antiemetic efficacy. Dexamethasone antiemetic efficacy alone or in combination has been reported in patients undergoing laparoscopic cholecystectomy –, other abdominal laparoscopic procedures, breast cancer surgery, large and small bowel surgery, total knee arthroplasty, joint replacement surgery, gynecological laparoscopic procedures,, cesarean delivery, scoliosis correction surgery, vitrectomy under local anesthesia, and upper extremity surgery as well as in endoscopic adenoidectomy and strabismus correction surgery in children. Interestingly, there are reports that dexamethasone did not reduce PONV in patients undergoing surgery for facial fracture, laparoscopic surgery for suspected appendicitis, and microvascular decompression surgery of the trigeminal nerve root. Singh et al. concluded that dexamethasone has equal antiemetic efficacy compared to 5-HT 3 receptor antagonists up to 24 hours after surgery. Concerns remain regarding potential complications (e.g. delayed wound healing, hyperglycemia, and risk of infections) in “at-risk” patient populations (e.g. diabetics),.

Betamethasone has also been shown to be an effective antiemetic. Aasboe et al. compared betamethasone 12 mg intramuscularly (IM) to saline when administered 30 minutes before the start of surgery and reported that betamethasone reduced both postoperative pain and nausea in outpatients undergoing ambulatory foot (hallux valgus) surgery or hemorrhoid procedures. Comparable results were attained in patients undergoing ambulatory surgery and elective breast surgery and in high-risk cardiac surgical patients. However, in a placebo-controlled study by Nordin et al. comparing betamethasone 8 mg per os (PO) and betamethasone 8 mg IV when administered 1 hour before induction of anesthesia in patients undergoing elective Roux-y-gastric bypass, betamethasone was of limited benefit in preventing PONV.

NK-1 receptor antagonists. NK-1 receptor antagonists with long elimination half-life values are effective for the prophylaxis and treatment of PONV. Gesztesi et al. found that the NK-1 receptor antagonist CP-122,721 (200 mg PO) decreased emetic episodes compared with ondansetron (4 mg IV) during the first 24 hours after gynecologic surgery. The NK-1 receptor antagonist aprepitant appears to be more effective in decreasing PONV as compared with ondansetron,. Aprepitant alone or in combination was associated with a low overall incidence of PONV, in patients undergoing laparoscopic surgery, craniotomy, mastectomy and thyroidectomy, and elective surgery and in pediatric patients. Because of its high cost, aprepitant should be used only in patients at high risk of developing PONV and in those who could experience serious adverse outcomes due to PONV as well as in patients who may have side effects from less-expensive antiemetic drugs,.

Fosaprepitant 150 mg IV, a water-soluble lipid formulation of the NK-1 receptor antagonist, was compared to IV ondansetron 4 mg when administered before induction of anesthesia in patients with a moderate-to-high risk of PONV (Apfel simplified score ≥2) undergoing general anesthesia, obtaining a greater decrease in the incidence of vomiting during the first 48 hours after surgery. Similar results were reported in patients undergoing craniotomy and gynecologic abdominal surgery with patient-controlled epidural analgesia.

Butyrophenone. Droperidol, which acts on central dopamine receptors, is a highly cost-effective antiemetic treatment, regardless of the risk of extrapyramidal side effects and the potential for prolonging the electrocardiographic QT interval. Multiple well-controlled, randomized, comparative clinical trials have validated droperidol to be as safe and effective as the more costly 5-HT 3 and NK-1 antagonists,. There is minimal to no clinical significance in the degree of QT-interval prolongation correlating to antiemetic doses of the drug. The risk of QTc prolongation was actually decreased by administrating a combination of droperidol and a 5-HT 3 receptor antagonist. The combination of dexamethasone, ondansetron, and droperidol is highly efficacious in preventing PONV in adults. Clinical studies have stated the efficacy of droperidol in reducing PONV in different surgical procedures such as tonsillectomy in children and ambulatory surgery. Nevertheless, Bourdaud et al. compared the efficacy of a combination of ondansetron (100 µg/kg, IV), dexamethasone (125 µg/kg, IV), and droperidol (50 µg/kg, IV) in pediatric patients at high risk of POV and concluded that adding droperidol to a prophylactic combination of ondansetron and dexamethasone did not decrease the incidence of POV below that obtained with the two drugs alone, though the addition of droperidol increased the risk of drowsiness. Singh et al. reported that haloperidol was equivalent to the popular 5-HT 3 receptor antagonists in preventing vomiting on the first day after surgery. The incidence of QTc prolongation with haloperidol is statistically equivalent to the 5-HT 3 antagonists. Brettner et al. found gender-specific differences in the incidence of PONV (female > males) in the PACU after low-dose haloperidol (0.5 mg IV).

Dopamine antagonists and gastrokinetic drugs. Metoclopramide is one of the most utilized antiemetics for treating PONV when 5-HT 3 antagonists, dexamethasone, and/or droperidol prophylaxis is unsuccessful. A systematic review reported that in patients undergoing cesarean delivery under neuraxial anesthesia, the use of metoclopramide 10 mg IV was effective and safe for the prevention of early PONV. Amisulpride has been found to be effective in treating PONV after failed prophylaxis in treating patients at low-to-moderate risk of PONV who received no prior PONV prophylaxis, patients at moderate-to-high risk, or patients at high risk of PONV who developed emetic symptoms after prophylaxis with ondansetron or dexamethasone.

Anticholinergics. Scopolamine is a centrally active anticholinergic drug and can be as efficacious as droperidol (1.25 mg) or ondansetron (4 mg) in reducing PONV in the early and late postoperative periods. Nonetheless, there are concerns about using it routinely for antiemetic prophylaxis because of its slow onset of action and adverse effects (e.g. dry mouth, drowsiness, and visual disturbances). Despite this, scopolamine remains a suitable and cost-effective substitute to ondansetron in multimodal treatment prophylaxis in patients with motion-induced emesis and high-risk patients undergoing major operation. Apfel et al. reported that transdermal scopolamine (TDS) was associated with significant reductions in PONV during the first 24 hours after anesthesia. TDS was also associated with a higher prevalence of visual disturbances at 24–48 hours after surgery. Pergolizzi et al. concluded that TDS significantly reduces PONV/PDNV in many different types of surgical patients, and it is recommended in guidelines as a first-line or second-line prophylactic antiemetic. Kassel et al. concluded that scopolamine should be reconsidered as a routine agent for PONV prevention in the general surgical population but should be avoided in both pediatric and elderly surgical populations.

Drugs with opioid-sparing effects contributing to antiemetic activity. Neuromodulator drugs such as tricyclic antidepressants, gabapentin, olanzapine, mirtazapine, benzodiazepines, clonidine, and cannabinoids have been reported to be effective in preventing nausea and vomiting as a result of their opioid-sparing effects. Dexmedetomidine has demonstrated opioid-sparing effects in elderly patients undergoing epiduroscopy, in patients with a high risk of PONV following gynecological laparoscopic surgery, and in patients undergoing other types of surgical procedures. However, dexmedetomidine has produced side effects (e.g. bradycardia and hypotension). Gabapentin has been reported to produce anti-nauseant effects in various clinical settings owing to opioid-sparing effects –. However, White et al. found that preoperative pregabalin failed to decrease either PONV or postoperative pain after major gynecologic surgery. The administration of dimenhydrinate is limited because of its adverse events profile (e.g. dizziness, sedation, and dry mouth, throat, and nose). Kizilcik et al. found that the dexamethasone-dimenhydrinate combination was effective for PONV prophylaxis. Mirtazapine, a 5-HT 3 receptor antagonist capable of blocking adrenergic receptors, has been shown to be effective for PONV prophylaxis and to decrease nausea and vomiting in patients after a variety of surgical procedures,. Midazolam, a short-acting benzodiazepine, has been reported to reduce the incidence of PONV and provide an anxiolytic effect in patients undergoing cholecystectomy, appendectomy, gynecological surgery, middle ear surgery, thyroidectomy, and intragastric balloon placement –. Antipsychotic therapies including olanzapine, aripiprazole, and risperidone have been reported to reduce the need for antiemetic medication in the PACU. Kang et al. reported that the combination of palonosetron 0.075 mg and the muscle relaxant reversal drug sugammadex 2 mg/kg reduced the incidence of PONV in patients undergoing microvascular decompression. Acetaminophen preoperatively has been associated with a reduced incidence of PONV in children undergoing strabismus surgery. However, Roberts et al. found that children who received IV acetaminophen were more likely to experience PONV. Nabilone, a synthetic cannabinoid, has proven clinical utility in chemotherapy-related nausea and vomiting and PONV. However, oral nabilone 0.5 mg (versus placebo) in patients with preoperative risk of PONV greater than 60% was reported to be ineffective when given prior to surgery. The addition of nalbuphine (0.5 mg) reduced the incidence and severity of PONV and pruritus after cesarean delivery. Perioperative intravenous lidocaine infusion (1–5 mg/kg/hour or 2–4 mg/kg/hour) has been reported to reduce PONV, pain scores, perioperative opioid consumption, and duration of hospital stay and accelerate the restoration of bowel function –. However, Dewinter et al. failed to confirm these findings, concluding that systemic lidocaine had no analgesic effect when added to an opioid-based anesthetic regimen for arthrodesis procedures. Clonidine is an alpha 2 adrenergic agonist which has been used both orally and via neuraxial administration as an adjuvant for the treatment of pain and PONV in a wide variety of surgical procedures (e.g. breast, thyroid, and lower abdominal surgery and laparoscopic cholecystectomy in adults and strabismus surgery in children). Clonidine has been shown to improve pain, reduce morphine consumption, decrease PONV, reduce postoperative shivering, and improve hemodynamic and sympathetic stability –. However, there are also published studies which have contradicted these findings, –. Some also reported higher Ramsay sedation scores with clonidine.

Adequate IV fluid hydration is an effective strategy for decreasing the baseline risk for PONV. It has been suggested that early rehydration in surgical patients with prolonged fasting decreases PONV. Studies have reported that the administration of perioperative IV colloid, perioperative IV crystalloid,, and Ringer's lactate (30 mL/kg/hour) and early postoperative oral fluid intake were associated with a lower incidence of PONV. It has also been suggested that the administration of a perioperative infusion of dextrose reduces PONV. Nevertheless, two meta-analyses, reported that perioperative IV dextrose did not reduce the risk for PONV but was effective in reducing the need for antiemetic rescue medications after general anesthesia.

Ginger root is an herbal compound which contains gingerol (Ginjervel) and shogaol (Chagall), which reduce stomach contractions and increase the activity of the gastrointestinal tract and motility due to anticholinergic and antiserotonergic actions, increasing gastric emptying –. Ginger possesses antiserotonergic activity and has free radical scavenging effects on free radicals that induce vomiting,. Ginger is safe and well tolerated, which appears to be useful in both pregnancy – and chemotherapy-induced PONV, reducing the need for antiemetic rescue medications –. Ginger has also reduced PONV in patients undergoing cholecystectomy –, nephrectomy,, gynecologic/obstetric surgery –, ambulatory surgery, cataract surgery, and thyroidectomy. However, there are also several studies that have reported contradictory results –. Alcohol pads containing isopropyl alcohol, when applied under the nose, are a highly cost-effective treatment for transient PONV in adults and children –.

Aromatherapy such as essential oils (i.e. spearmint, peppermint, ginger, lavender, and blended orange and peppermint) has also been demonstrated to provide benefits in reducing PONV and PDNV when added to a standard antiemetic treatment regimen, –. However, there are other authors who have not found any evidence that aromatherapy decreases PONV –.

Nonpharmacologic therapies for PONV and PDNV

A wide variety of nonpharmacologic techniques have been used to control emetic symptoms in the postoperative period alone or in combination, including acupressure,, acupuncture,, and transcutaneous electrical nerve stimulation (TENS), –. TENS combined with a wristband pressing on Neiguan P-6 acupoint was effective in preventing PONV after laparoscopic cholecystectomy. White et al. reported that TENS and ondansetron was effective in PONV prophylaxis. These results were later confirmed when acustimulation was shown to possess analgesic effects. The adjunct use of the Pressure Right acupressure device was shown to improve the emetic potency of commonly used drugs for antiemetic prophylaxis (e.g. ondansetron, droperidol, and dexamethasone) after major laparoscopic surgery. Lee et al. described the use of P-6 acupoint stimulation for PONV as superior to non-acupoint or sham treatments in reducing PONV and need for rescue antiemetic treatment in the postoperative period. Acupuncture at ear acupoint alone or in combination with stimulation at the wrist (P-6 acupoint) has been found to be an effective treatment to reduce PONV –. Similar results with dry cupping at the P-6 acupoint and preoperative electro-acupuncture were found. The Society for Ambulatory Anesthesia guidelines mentioned that stimulation of the P-6 acupoint is an effective complementary method to reduce PONV. Other studies support the beneficial effect of P-6 acupoint stimulation in reducing PONV and the need for rescue antiemetics, –. Acupoints such as Laogong (PC8), Waiguan (SJ5), Zusanli (ST36), Hegu (LI4), and Quchi (LI11) can be used for reducing PONV as well –. In the pediatric population, acupuncture, electroacupuncture, and laser acupuncture at the P-6 acupoint have all been used to prevent POV after tonsillectomy and/or adenoidectomy, hernia repair, circumcision, orchidopexy, chemotherapy, and strabismus procedures, –. However, there are other studies that used these modalities in both adults and children with negative results –. Chewing gum was also associated with a lower incidence of postoperative ileus and PONV –; however, Ge et al. found no difference.

Music therapy has been alleged to decrease patient anxiety, pain, and emesis, hospital length of stay, and fatigue after surgeries such as hernia repair, coronary angiography, valve replacement, cardiac surgery, breast surgery, elective cesarean section, sigmoidoscopy, colonoscopy, knee arthroplasty, hand surgery, cystoscopy, hysterectomy, gynecological surgery, varicose vein surgery, general abdominal surgery, laparoscopic cholecystectomy, and urological procedures, –. However, other studies showed that music therapy did not significantly reduce PONV,. Other alternative modalities such as foot massage were reported to decrease pain and incidence of nausea and improve blood circulation in patients who underwent laparoscopic cholecystectomy. Frozen ice pops reduced PONV in patients at high risk of PONV who were undergoing major joint replacement surgery. Another important therapeutic goal for PONV prophylaxis is to avoid surgical oxygen desaturation and maintain muscular tissue oxygen saturation at >70% of the baseline values and a normal cerebral oxygen saturation. These nonpharmacologic alternative therapies can produce additive effects to standard antiemetic drugs without increasing side effects or producing adverse drug interactions.

Preventing PONV and PDNV through multimodal prophylaxis

PONV has multiple factors contributing to its etiology, leading to an increased awareness in the use of combined therapies that incorporate more than two strategies depending on the overall risk for any given patient. Multimodal interventions not only reduce PONV but also, more importantly, enhance patient comfort after surgery. There is no evidence to date to suggest that any one specific antiemetic therapy is especially effective for a particular patient profile or operation. Therefore, a combination of antiemetic drug therapies that act at different neuroreceptor sites has been recommended for at-risk patients. Some clinicians used a simple method involving the administration of one antiemetic medication for each of the Apfel PONV risk factors. It is commonly accepted that increasing the number of administered antiemetics from one to three improves PONV prophylactic benefit for higher risk patients. Clinical research has shown combining prophylactic antiemetic drugs can lower the rate of PONV and PDNV occurrence as well as improve the patient’s satisfaction with and assist in their recovery in comparison to using a single antiemetic drug,. Implementation of PONV guidelines and the assessment of the risk of PONV using the Apfel scoring system reduced the incidence of PONV in patients undergoing ambulatory breast surgery and improved anesthesia providers' compliance with a preoperative PONV risk assessment, –. A combination therapy with antiemetic drugs acting at separate receptor sites should be provided to patients with moderate-to-high risk for PONV. A multimodal approach provides a considerable decrease in the incidence of PONV to less than 10% along with an increase in patient satisfaction and reduced side effects,.

Bruderer et al. proposed a standardized PONV prophylaxis for ambulatory surgery based on patients’ Apfel risk-score (0–4): ondansetron (Apfel risk-score 2), additional dexamethasone (Apfel risk-score 3), and additional droperidol (Apfel risk-score 4). These investigators achieved low rates of PONV in ~90% of their patients, and PDNV was not a problem on the first day after surgery. In fact, pain after discharge was a much more common problem. Bergese et al. found that triple therapy with scopolamine, ondansetron, and dexamethasone was an effective regime to prevent PONV in moderate- to high-risk patients undergoing craniotomy procedures. Dexamethasone and a 5-HT 3 receptor antagonist combination has superior efficacy and thus it is recommended as the "ideal" choice for routine PONV prophylaxis. However, a study including same-day surgery patients with varying PONV risk factors revealed that adding ondansetron to a combination of low-dose droperidol and dexamethasone failed to increase antiemetic efficacy,. No difference was observed when comparing efficacy among combinations of 5-HT 3 receptor antagonist with dexamethasone, 5-HT 3 receptor antagonist with droperidol, or dexamethasone with droperidol. Interestingly, there was no reduction in PONV in the combinations containing metoclopramide compared to monotherapy alone.

As most patients undergoing surgery have one or two risk factors and 20–40% of these patients are expected to suffer from PONV if they do not receive a prophylactic antiemetic drug, combination antiemetic therapies have become increasingly vital in preventing PONV. Ideally, prophylaxis for PDNV would continue much further than the point of discharge from hospital or free-standing surgical care facility,. Recent research focused on different antiemetic drugs administered at various time points after surgery has evaluated the effects on reducing PDNV. For example, a study demonstrated that patients who received the combination of ondansetron (4 mg IV) and an oral disintegrating tablet of ondansetron (8 mg) immediately before discharge had less severe nausea and fewer vomiting episodes compared to IV ondansetron alone after discharge (3% versus 23%). In a multi-center study, intraoperative dexamethasone did not appear to reduce PONV in the PACU but significantly reduced PDNV. Dewinter et al. tested the effectiveness of a simplified algorithm for PONV prophylaxis with female patients receiving triple IV prophylaxis (dexamethasone and ondansetron plus either a target-controlled infusion with propofol or droperidol) and male patients received double prophylaxis with dexamethasone IV and ondansetron IV. This simplified algorithm for PONV prophylaxis resulted in a significant reduction in the incidence of PONV and better compliance with the PONV algorithm (46% versus 18%, P = 0.0001). Kumar et al. compared a single dose of palonosetron 0.075 mg IV plus dexamethasone 4 mg IV to ondansetron 8 mg IV plus dexamethasone 4 mg IV (with ondansetron 4 mg administered every 8 hours IV for 48 hours) for PONV prophylaxis in post-chemotherapy ovarian cancer surgery patients receiving opioid-based patient-controlled analgesia (PCA). Ryu found that palonosetron prophylaxis reduced the incidence and severity of PONV in high-risk patients undergoing total knee arthroplasty with a multimodal analgesia protocol consisting of spinal anesthesia, a continuous femoral nerve block, and fentanyl-based IV PCA. The increasing use of inexpensive, disposable acupressure devices (e.g. Relief Band, Pressure Right) should also be considered in patients at high risk for PDNV. In addition, these patients should be given instructions for appropriate “rescue” antiemetic treatment before they are discharged home. Recommendations for optimal antiemetic dosing when utilizing a combination “multimodal” therapy consisting of dexamethasone, droperidol, and ondansetron are as follows: ondansetron 4 mg IV, 4–8 mg of IV dexamethasone, and 0.625–1.25 mg of IV droperidol. Another study confirmed that low-dose granisetron (0.1 mg IV) in combination with dexamethasone (8 mg IV) is as effective as the combination of IV ondansetron (4 mg) and IV dexamethasone (8 mg). Therefore, antiemetic drugs are now commonly administered at both the start and the end of surgery to patients considered to be at high risk of developing PONV. Adherence to validated PONV prophylaxis guidelines should be carefully evaluated before the patient is discharged from the PACU to guarantee that patients have received appropriate PONV prophylaxis during the perioperative period.

Combined treatments for managing established PONV

Swift antiemetic management is mandated whenever PONV happens in patients who either did not obtain adequate prophylaxis or had ineffective prophylaxis. If PONV occurs in the immediate postoperative phase (within 6 hours postoperatively), despite antiemetic prophylaxis, an antiemetic belonging to a pharmacologic class other than that of the prophylactic drug regimen should be given. However, if the PONV occurs over 6 hours after surgery, it is suggested that a repeat dose of the original prophylactic is administered. If no prophylaxis was given, the recommended treatment is low-dose 5-HT 3 antagonist (e.g. ondansetron 1–2 mg IV). Alternative treatments for active PONV include intravenous metoclopramide (10 mg), droperidol (0.625 mg), promethazine (6.25–12.5 mg), dolasetron (12.5 mg), granisetron (0.1 mg), palonosetron (0.075mg), or tropisetron (0.5 mg),. Algorithms describing how to identify high-risk patients and how to guide the administration of multimodal treatments can significantly reduce the incidence of PONV and PDNV, –. Yazbeck-Karam et al. investigated haloperidol versus ondansetron for the treatment of established PONV following general anesthesia and found that haloperidol (1 mg IV) was not inferior to ondansetron (4 mg IV) in the early treatment of established PONV. However, haloperidol was associated with an increased level of sedation. Hu et al. combined a low dose of 2.5 μg/kg palonosetron with 15 μg/kg of droperidol and achieved a similar prophylactic effect as a higher 7.5 μg/kg dose of palonosetron compared to 7.5 μg/kg alone for treating emesis after eye surgery. For the treatment of existing PONV prior to discharge, a multimodal strategy should be considered because the recurrence rate of PONV over the subsequent 24 hours is 35–50%. A combination of low-dose ondansetron plus dexamethasone and droperidol or haloperidol has been found to be superior to monotherapy alone for the treatment of PONV in the PACU. Those interventions have proven to be effective for both prophylaxis for and treatment of PONV. Therneau et al. found that the addition of aprepitant 40 mg PO to a multimodal antiemetic prophylactic regimen (triple antiemetic prophylaxis with dexamethasone, droperidol, and ondansetron) was associated with significant reduction of PONV during both the early recovery period and the first 48 hours postoperatively in patients undergoing bariatric surgery. Trimas and Trimas concluded that a single dose of aprepitant 40 mg PO administered preoperatively can decrease the incidence of PONV in the early postoperative period after facial plastic surgery compared with ondansetron alone.

Summary of current recommendations for reducing the risk of PONV and PDNV

The management strategy for each individual patient should be based on the level of risk for PONV, the patient’s pre-existing condition, patient preference, and cost efficiency. Patients should be informed about the potential consequences of PONV and PDNV during the preoperative evaluation. In addition to using a combination of antiemetic drugs with different mechanisms of action, the multifactorial etiology of PONV would also be best addressed by adopting a multimodal approach to pain management and minimizing baseline risk factors associated with PONV and PDNV in high-risk patients ( Table 3). Several effective strategies are recommended for reducing the baseline risk for PONV ( Table 6): (1) routine use of local anesthesia and regional anesthesia (e.g. local infiltration and/or peripheral nerve blocks); (2) propofol induction and maintenance infusion during general anesthesia and monitored anesthesia care (MAC); (3) minimization of perioperative opioid analgesics; (4) minimization of concentrations of volatile anesthetics; (5) minimization of the use of nitrous oxide and reversal drugs; and (6) ensuring adequate perioperative hydration,,,,. If general anesthesia is utilized, substituting a propofol infusion for maintenance of anesthesia in place of inhaled volatile anesthetics will reduce the risk of PONV. A combination of propofol and air/oxygen had additive effects, reducing the risk of early PONV by approximately 25%. The non-opioid analgesic drugs (e.g. nonsteroidal anti-inflammatory drugs [NSAIDs] like ketorolac or ketoprofen, cyclooxygenase-2 inhibitors [COX-2] like celecoxib or meloxicam, and acetaminophen [oral or intravenous]) should be part of a multimodal perioperative analgesic regimen, –. Pain and PONV after breast cancer surgery were more effectively reduced with a multimodal regimen utilizing non-opioid analgesics and antiemetics compared to a one- or two-component regimen. Similar results were found when using an opioid-free TIVA technique for bariatric surgery. Adequate preoperative and intraoperative IV fluid hydration is also an effective strategy for decreasing the baseline risk for PONV,,. Nitrous oxide had little impact when used for procedures lasting less than 1 hour,. Thus, nitrous oxide may be a good option for the short ambulatory procedures to facilitate a faster recovery from anesthesia. Although previous studies suggested that neostigmine produced dose-related increases in PONV,, a more recent study suggested that minimization of the neostigmine dosage failed to reduce the baseline risk of developing PONV. Sugammadex rapidly reverses the neuromuscular blockade caused by steroid-based muscle relaxants; it is a feasible alternative to neostigmine, edrophonium, or pyridostigmine in “at-risk” patients administered non-depolarizing muscle relaxants intraoperatively. Yağan et al. reported that reversal with sugammadex 2 mg/kg (compared to neostigmine 50 μg/kg plus atropine 0.2 mg/kg) was associated with a lower incidence of PONV in the first hour after surgery and required less rescue antiemetic therapy in the first 24 hours after breast, strabismus, and middle ear surgery. Tas Tuna et al. confirmed these results in patients undergoing elective laparoscopic cholecystectomy surgery. PONV prophylaxis is rarely warranted in low-risk patients. However, moderate-risk patients benefit from single or even often multiple antiemetic drug interventions. Use of two antiemetic interventions is recommended for adults and children at moderate risk, and three (“triple”) interventions should be administered to all high-risk patients,. The occurrences of PONV in patients who have received appropriate prophylactic antiemetic therapy should be treated aggressively using antiemetic drugs from a different pharmacologic class,. In patients who did not receive antiemetic prophylaxis, first consider using a generic serotonin antagonist. Do not repeat drugs used for prophylaxis until 6 hours have elapsed after completion of surgery. Do not repeat the use of transdermal scopolamine. If refractory symptoms persist, carefully evaluate for other causative factors such as excessive opioid use, draining blood into the gastrointestinal tract or nasopharynx, or gastrointestinal obstruction/ileus. Nonetheless, recognize that PONV/PDNV can still occur despite optimal prophylaxis in high-risk populations. Communication among the patient, anesthesiology team, surgical team, and perioperative nursing staff is essential for optimizing patient outcomes.

References 444

  1. 1.
    Nausea: a review of pathophysiology and therapeutics · 2016
    Not checked
  2. 2.

    Balaban CD Yates BJ: What is nausea? A historical analysis of changing views. Auton Neurosci. 2017;202:5–17.

    Not in our library10.1016/j.autneu.2016.07.003

  3. 3.

    Metz A Hebbard G: Nausea and vomiting in adults--a diagnostic approach. Aust Fam Physician. 2007;36(9):688–92.

    Not in our library

  4. 4.

    American Gastroenterological Association: American Gastroenterological Association medical position statement: Nausea and vomiting. Gastroenterology. 2001;120(1):261–3.

    Not in our library10.1053/gast.2001.20515

  5. 5.

    Öbrink E Jildenstål P Oddby E: Post-operative nausea and vomiting: Update on predicting the probability and ways to minimize its occurrence, with focus on ambulatory surgery. Int J Surg. 2015;15:100–6.

    Not in our library10.1016/j.ijsu.2015.01.024

  6. 6.

    Veiga-Gil L Pueyo J López-Olaondo L: Postoperative Nausea and Vomiting: Physiopathology, Risk Factors, Prophylaxis and Treatment. Rev Esp Anestesiol Reanim. 2017;64(4):223–32.

    Not in our library10.1016/j.redar.2016.10.001

  7. 7.

    Pierre S Whelan R: Nausea and vomiting after surgery. Continuing Education in Anaesthesia Critical Care & Pain. 2013;13(1):28–32.

    Not in our library10.1093/bjaceaccp/mks046

  8. 8.

    Feinleib J Kwan LH Yamani A: Postoperative nausea and vomiting.2018 Reference Source

    Not in our library

  9. 9.

    Glass PSA White PF: Practice guidelines for the management of postoperative nausea and vomiting: Past, present, and future. Anesth Analg. 2007;105(6):1528–9.

    Not in our library10.1213/01.ane.0000295854.53423.8a

  10. 10.

    Fero KE Jalota L Hornuss C: Pharmacologic management of postoperative nausea and vomiting. Expert Opin Pharmacother. 2011;12(15):2283–96.

    Not in our library10.1517/14656566.2011.598856

  11. 11.

    Kovac AL: Update on the management of postoperative nausea and vomiting. Drugs. 2013;73(14):1525–47.

    Not in our library10.1007/s40265-013-0110-7

  12. 12.

    Cao X White PF Ma H: An update on the management of postoperative nausea and vomiting. J Anesth. 2017;31(4):617–26.

    Not in our library10.1007/s00540-017-2363-x

  13. 13.

    Apipan B Rummasak D Wongsirichat N: Postoperative nausea and vomiting after general anesthesia for oral and maxillofacial surgery. J Dent Anesth Pain Med. 2016;16(4):273–281.

    Not in our library10.17245/jdapm.2016.16.4.273

  14. 14.

    Dzwonczyk R Weaver TE Puente EG: Postoperative nausea and vomiting prophylaxis from an economic point of view. Am J Ther. 2012;19(1):11–5.

    Not in our library10.1097/mjt.0b013e3181e7a512

  15. 15.

    Bellville JW Bross IDJ Howland WS: Postoperative Nausea and Vomiting. IV. Factors Related to Postoperative Nausea and Vomiting. Anesthesiology. 1960;21:186–93.

    Not in our library10.1097/00000542-196003000-00009

  16. 16.

    Dinges HC Otto S Stay DK: Side Effect Rates of Opioids in Equianalgesic Doses via Intravenous Patient-Controlled Analgesia: A Systematic Review and Network Meta-analysis. Anesth Analg. 2019;129(4):1153–62.

    Not in our library10.1213/ane.0000000000003887

  17. 17.

    Phillips C Brookes CD Rich J: Postoperative nausea and vomiting following orthognathic surgery. Int J Oral Maxillofac Surg. 2015;44(6):745–51.

    Not in our library10.1016/j.ijom.2015.01.006

  18. 18.

    White PF O'Hara JF Roberson CR: The impact of current antiemetic practices on patient outcomes: A prospective study on high-risk patients. Anesth Analg. 2008;107(2):452–8.

    Not in our library10.1213/ane.0b013e31817b842c

  19. 19.

    López-Torres López J Piedracoba Cadahía D Alcántara Noalles MJ: Perioperative Factors That Contribute to Postoperative Pain and/or Nausea and Vomiting in Ambulatory Laparoscopic Surgery. Rev Esp Anestesiol Reanim. 2019;66(4):189–98.

    Not in our library10.1016/j.redar.2018.11.007

  20. 20.

    Kappen TH: Risk-tailored prophylaxis for postoperative nausea and vomiting: Has the big little problem gotten any smaller? Br J Anaesth. 2018;120(1):9–13.

    Not in our library10.1016/j.bja.2017.11.005

  21. 21.

    de Souza DS Costa AF Chaves GV: Predisposing factors for postoperative nausea and vomiting in gynecologic tumor patients. Support Care Cancer. 2016;24(11):4661–7.

    Not in our library10.1007/s00520-016-3311-2

  22. 22.

    Albuquerque AFM Queiroz SIM Germano AR: Factors associated to post-operative nausea and vomiting following oral and maxillofacial surgery: A prospective study. Oral Maxillofac Surg. 2017;21(1):49–54.

    Not in our library10.1007/s10006-016-0598-6

  23. 23.

    Dobbeleir M de Coster J Coucke W: Postoperative nausea and vomiting after oral and maxillofacial surgery: A prospective study. Int J Oral Maxillofac Surg. 2018;47(6):721–5.

    Not in our library10.1016/j.ijom.2017.11.018

  24. 24.

    Groene P Eisenlohr J Zeuzem C: Postoperative nausea and vomiting in bariatric surgery in comparison to non-bariatric gastric surgery. Wideochir Inne Tech Maloinwazyjne. 2019;14(1):90–5.

    Not in our library10.5114/wiitm.2018.77629

  25. 25.

    Halliday TA Sundqvist J Hultin M: Post-operative nausea and vomiting in bariatric surgery patients: An observational study. Acta Anaesthesiol Scand. 2017;61(5):471–9.

    Not in our library10.1111/aas.12884

  26. 26.

    Son J Yoon H: Factors Affecting Postoperative Nausea and Vomiting in Surgical Patients. J Perianesth Nurs. 2018;33(4):461–70.

    Not in our library10.1016/j.jopan.2016.02.012

  27. 27.

    White PF Sacan O Nuangchamnong N: The Relationship Between Patient Risk Factors and Early Versus Late Postoperative Emetic Symptoms. Anesth Analg. 2008;107(2):459–63.

    Not in our library10.1213/ane.0b013e31817aa6e4

  28. 28.

    Watcha MF White PF: Postoperative nausea and vomiting. Its etiology, treatment, and prevention. Anesthesiology. 1992;77(1):162–84.

    Not in our library10.1097/00000542-199207000-00023

  29. 29.

    Eberhart LHJ Geldner G Kranke P: The Development and Validation of a Risk Score to Predict the Probability of Postoperative Vomiting in Pediatric Patients. Anesth Analg. 2004;99(6):1630–7.

    Not in our library10.1213/01.ane.0000135639.57715.6c

  30. 30.

    Eberhart LHJ Morin AM Guber D: Applicability of risk scores for postoperative nausea and vomiting in adults to paediatric patients. Br J Anaesth. 2004;93(3):386–92.

    Not in our library10.1093/bja/aeh221

  31. 31.

    Kranke P Eberhart LH Toker H: A Prospective Evaluation of the POVOC Score for the Prediction of Postoperative Vomiting in Children. Anesth Analg. 2007;105(6):1592–7.

    Not in our library10.1213/01.ane.0000287816.44124.03

  32. 32.

    Efune PN Minhajuddin A Szmuk P: Incidence and factors contributing to postdischarge nausea and vomiting in pediatric ambulatory surgical cases. Paediatr Anaesth. 2018;28(3):257–63.

    Not in our library10.1111/pan.13333

  33. 33.

    Apfel CC Turan A Souza K: Intravenous acetaminophen reduces postoperative nausea and vomiting: A systematic review and meta-analysis. Pain. 2013;154(5):677–89.

    Not in our library10.1016/j.pain.2012.12.025

  34. 34.

    Palazzo M Evans R: Logistic regression analysis of fixed patient factors for postoperative sickness: a model for risk assessment. Br J Anaesth. 1993;70(2):135–40.

    Not in our library10.1093/bja/70.2.135

  35. 35.

    Koivuranta M Läärä E Snåre L: A survey of postoperative nausea and vomiting. Anaesthesia. 1997;52(5):443–449.

    Not in our library10.1111/j.1365-2044.1997.117-az0113.x

  36. 36.

    Sinclair DR Chung F Mezei G: Can Postoperative Nausea and Vomiting Be Predicted? Anesthesiology. 1999;91(1):109–18.

    Not in our library10.1097/00000542-199907000-00018

  37. 37.

    Apfel CC Heidrich FM Jukar-Rao S: Evidence-based analysis of risk factors for postoperative nausea and vomiting. Br J Anaesth. 2012;109(5):742–53.

    Not in our library10.1093/bja/aes276

  38. 38.

    Gan TJ Diemunsch P Habib AS: Consensus Guidelines for the Management of Postoperative Nausea and Vomiting. Anesth Analg. 2014;118(1):85–113.

    Not in our library10.1213/ane.0000000000000002

  39. 39.

    Rowley MP Brown TC: Postoperative vomiting in children. Anaesth Intensive Care. 1982;10(4):309–13.

    Not in our library10.1177/0310057x8201000402

  40. 40.

    Chandrakantan A Reinsel RA Jasiewicz R: An exploratory study of the relationship between postoperative nausea and vomiting and postdischarge nausea and vomiting in children undergoing ambulatory surgery. Paediatr Anaesth. 2019;29(4):353–60.

    Not in our library10.1111/pan.13612

  41. 41.

    Kocaturk O Keles S Omurlu IK: Risk factors for postoperative nausea and vomiting in pediatric patients undergoing ambulatory dental treatment. Niger J Clin Pract. 2018;21(5):597–602.

    Not in our library10.4103/njcp.njcp_129_17

  42. 42.

    Turgut HC Alkan M Kip G: Is age a determinant for nausea and vomiting in disabled patients after dental treatment under sedation? Niger J Clin Pract. 2017;20(11):1497–500.

    Not in our library10.4103/1119-3077.222296

  43. 43.

    Bourdaud N Devys JM Bientz J: Development and validation of a risk score to predict the probability of postoperative vomiting in pediatric patients: The VPOP score. Paediatr Anaesth. 2014;24(9):945–52.

    Not in our library10.1111/pan.12428

  44. 44.

    Cohen MM Cameron CB Duncan PG: Pediatric anesthesia morbidity and mortality in the perioperative period. Anesth Analg. 1990;70(2):160–7.

    Not in our library10.1213/00000539-199002000-00005

  45. 45.

    Schreiner MS Nicolson SC Martin T: Should children drink before discharge from day surgery? Anesthesiology. 1992;76(4):528–33.

    Not in our library10.1097/00000542-199204000-00007

  46. 46.

    Shen YD Chen CY Wu CH: Dexamethasone, ondansetron, and their combination and postoperative nausea and vomiting in children undergoing strabismus surgery: A meta-analysis of randomized controlled trials. Paediatr Anaesth. 2014;24(5):490–8.

    Not in our library10.1111/pan.12374

  47. 47.

    Apfel CC Kranke P Katz MH: Volatile anaesthetics may be the main cause of early but not delayed postoperative vomiting: A randomized controlled trial of factorial design. Br J Anaesth. 2002;88(5):659–68.

    Not in our library10.1093/bja/88.5.659

  48. 48.

    Yoon IJ Kang H Baek CW: Comparison of effects of desflurane and sevoflurane on postoperative nausea, vomiting, and pain in patients receiving opioid-based intravenous patient-controlled analgesia after thyroidectomy: Propensity score matching analysis. Medicine (Baltimore). 2017;96(16):e6681.

    Not in our library10.1097/md.0000000000006681

  49. 49.

    Firoozabadi MD Rahmani H: Prevention of Nausea and Vomiting: Methods and Utility after Surgery in Cancer Patients? Asian Pac J Cancer Prev. 2015;16(7):2629–35.

    Not in our library10.7314/apjcp.2015.16.7.2629

  50. 50.

    Prathep S Mahattanaporn S Wasinwong W: Target Controlled Infusion versus Sevoflurane/Desflurane Anesthesia for Laparoscopic Cholecystectomy: Comparison Postoperative Nausea/Vomiting and Extubation Time. J Med Assoc Thai. 2015;98(12):1187–92.

    Not in our library

  51. 51.

    Tramèr MR Fuchs-Buder T: Omitting antagonism of neuromuscular block: Effect on postoperative nausea and vomiting and risk of residual paralysis. A systematic review. Br J Anaesth. 1999;82(3):379–86.

    Not in our library10.1093/bja/82.3.379

  52. 52.

    Sansonnens J Taffé P Burnand B: Higher occurrence of nausea and vomiting after total hip arthroplasty using general versus spinal anesthesia: An observational study. BMC Anesthesiol. 2016;16:44.

    Not in our library10.1186/s12871-016-0207-0

  53. 53.

    Seki H Furumoto K Sato M: Effects of epidural anesthesia on postoperative nausea and vomiting in laparoscopic gynecological surgery: A randomized controlled trial. J Anesth. 2018;32(4):608–15.

    Not in our library10.1007/s00540-018-2525-5

  54. 54.

    Semiz A Akpak YK Yılanlıoğlu NC: Prediction of intraoperative nausea and vomiting in caesarean delivery under regional anaesthesia. J Int Med Res. 2017;45(1):332–9.

    Not in our library10.1177/0300060516680547

  55. 55.

    Rivedal DD Nayar HS Israel JS: Paravertebral block associated with decreased opioid use and less nausea and vomiting after reduction mammaplasty. J Surg Res. 2018;228:307–13.

    Not in our library10.1016/j.jss.2018.03.018

  56. 56.

    Steinhaus ME Rosneck J Ahmad CS: Outcomes After Peripheral Nerve Block in Hip Arthroscopy. Am J Orthop (Belle Mead NJ). 2018;47(6).

    Not in our library10.12788/ajo.2018.0049

  57. 57.
    Improved analgesia and reduced post-operative nausea and vomiting after implementation of an enhanced recovery after surgery (ERAS) pathway for total mastectomy · 2018
    No notice
  58. 58.

    Ma K Wu X Chen Y: Effect of multimodal intervention on postoperative nausea and vomiting in patients undergoing gynecological laparoscopy. J Int Med Res. 2019;47(5):2026–33.

    Not in our library10.1177/0300060519835700

  59. 59.

    Abubaker AK Al-Qudah MA: The Role of Endoscopic Sphenopalatine Ganglion Block on Nausea and Vomiting After Sinus Surgery. Am J Rhinol Allergy. 2018;32(5):369–73.

    Not in our library10.1177/1945892418782235

  60. 60.

    Sidiropoulou T Buonomo O Fabbi E: A prospective comparison of continuous wound infiltration with ropivacaine versus single-injection paravertebral block after modified radical mastectomy. Anesth Analg. 2008;106(3):997-1001, table of contents.

    Not in our library10.1213/ane.0b013e31816152da

  61. 61.

    White PF White LM Monk T: Perioperative Care for the Older Outpatient Undergoing Ambulatory Surgery. Anesth Analg. 2012;114(6):1190–215.

    Not in our library10.1213/ane.0b013e31824f19b8

  62. 62.

    White PF: Pain management for the elderly in the ambulatory setting. Pain Manag. 2015;5(4):233–6.

    Not in our library10.2217/pmt.15.28

  63. 63.

    Li CC Chen SS Huang CH: Fentanyl-induced cough is a risk factor for postoperative nausea and vomiting. Br J Anaesth. 2015;115(3):444–8.

    Not in our library10.1093/bja/aev157

  64. 64.

    Hozumi J Egi M Sugita S: Dose of intraoperative remifentanil administration is independently associated with increase in the risk of postoperative nausea and vomiting in elective mastectomy under general anesthesia. J Clin Anesth. 2016;34:227–31.

    Not in our library10.1016/j.jclinane.2016.04.018

  65. 65.

    Liu Y Yang L Tao SJ: Effects of hydromorphone and morphine intravenous analgesia on plasma motilin and postoperative nausea and vomiting in patients undergoing total hysterectomy. Eur Rev Med Pharmacol Sci. 2018;22(17):5697–703.

    Not in our library10.26355/eurrev_201809_15837

  66. 66.

    Palumbo P Usai S Amatucci C: Postoperative nausea and vomiting (PONV) in outpatient repair of inguinal hernia. Ann Ital Chir. 2018;89:75–80.

    Not in our library

  67. 67.

    Tao B Liu K Wang D: Effect of Intravenous Oxycodone Versus Sufentanil on the Incidence of Postoperative Nausea and Vomiting in Patients Undergoing Gynecological Laparoscopic Surgery. J Clin Pharmacol. 2019;59(8):1144–50.

    Not in our library10.1002/jcph.1408

  68. 68.

    Han L Su Y Xiong H: Oxycodone Versus Sufentanil in Adult Patient-Controlled Intravenous Analgesia After Abdominal Surgery: A Prospective, Randomized, Double-Blinded, Multiple-Center Clinical Trial. Medicine (Baltimore). 2018;97(31):e11552.

    Not in our library10.1097/md.0000000000011552

  69. 69.

    Watanabe T Moriya K Tsubokawa N: Effect of remifentanil on postoperative nausea and vomiting: A randomized pilot study. J Anesth. 2018;32(5):781–5.

    Not in our library10.1007/s00540-018-2550-4

  70. 70.

    Devys JM Mora A Plaud B: Intrathecal + PCA morphine improves analgesia during the first 24 hr after major abdominal surgery compared to PCA alone. Can J Anesth. 2003;50(4):355–61.

    Not in our library10.1007/bf03021032

  71. 71.

    de Pietri L Siniscalchi A Reggiani A: The use of intrathecal morphine for postoperative pain relief after liver resection: A comparison with epidural analgesia. Anesth Analg. 2006;102(4):1157–63.

    Not in our library10.1213/01.ane.0000198567.85040.ce

  72. 72.

    Dereu D Savoldelli GL Mercier Y: The Impact of a Transversus Abdominis Plane Block Including Clonidine vs. Intrathecal Morphine on Nausea and Vomiting After Caesarean Section: A Randomised Controlled Trial. Eur J Anaesthesiol. 2019;36(8):575–82.

    Not in our library10.1097/eja.0000000000001013

  73. 73.

    Peivandi S Habibi MR Baradari AG: The Effect of Adding Low-Dose Naloxone to Intrathecal Morphine on Postoperative Pain and Morphine Related Side Effects after Cesarean Section: A Double-Blind, Randomized, Clinical Trial. Open Access Maced J Med Sci. 2019;7(23):3979–83.

    Not in our library10.3889/oamjms.2019.852

  74. 74.

    Sneyd JR Carr A Byrom WD: A meta-analysis of nausea and vomiting following maintenance of anaesthesia with propofol or inhalational agents. Eur J Anaesthesiol. 1998;15(4):433–45.

    Not in our library10.1046/j.1365-2346.1998.00319.x

  75. 75.

    Bhakta P Ghosh BR Singh U: Incidence of postoperative nausea and vomiting following gynecological laparoscopy: A comparison of standard anesthetic technique and propofol infusion. Acta Anaesthesiol Taiwan. 2016;54(4):108–13.

    Not in our library10.1016/j.aat.2016.10.002

  76. 76.

    White PF: Anesthesiology-important advances in clinical medicine: Outpatient anesthesia techniques: continuous intravenous infusion of anesthetic agents. West J Med. 1984;140(3):437–8.

    Not in our library

  77. 77.

    Meng QT Cao C Liu HM: Safety and efficacy of etomidate and propofol anesthesia in elderly patients undergoing gastroscopy: A double-blind randomized clinical study. Exp Ther Med. 2016;12(3):1515–24.

    Not in our library10.3892/etm.2016.3475

  78. 78.

    Avramov MN Husain MM White PF: The Comparative Effects of Methohexital, Propofol, and Etomidate for Electroconvulsive Therapy. Anesth Analg. 1995;81(3):596–602.

    Not in our library10.1097/00000539-199509000-00031

  79. 79.

    Gazdag G Kocsis N Tolna J: Etomidate versus propofol for electroconvulsive therapy in patients with schizophrenia. J ECT. 2004;20(4):225–9.

    Not in our library10.1097/00124509-200412000-00007

  80. 80.

    Gholipour Baradari A Firouzian A Zamani Kiasari A: Effect of Etomidate Versus Combination of Propofol-Ketamine and Thiopental-Ketamine on Hemodynamic Response to Laryngoscopy and Intubation: A Randomized Double Blind Clinical Trial. Anesth Pain Med. 2016;6(1):e30071.

    Not in our library10.5812/aapm.30071

  81. 81.

    Nesher N Serovian I Marouani N: Ketamine spares morphine consumption after transthoracic lung and heart surgery without adverse hemodynamic effects. Pharmacol Res. 2008;58(1):38–44.

    Not in our library10.1016/j.phrs.2008.06.003

  82. 82.

    Vadivelu N Schermer E Kodumudi V: Role of ketamine for analgesia in adults and children. J Anaesthesiol Clin Pharmacol. 2016;32(3):298.

    Not in our library10.4103/0970-9185.168149

  83. 83.

    Pan L Shen Y Ma T: The efficacy of ketamine supplementation on pain management for knee arthroscopy: A meta-analysis of randomized controlled trials. Medicine (Baltimore). 2019;98(27):e16138.

    Not in our library10.1097/md.0000000000016138

  84. 84.

    Brinck E Tiippana E Heesen M: Perioperative intravenous ketamine for acute postoperative pain in adults. Cochrane Database Syst Rev. 2018;12(12):CD012033.

    Not in our library10.1002/14651858.cd012033.pub4

  85. 85.

    Moro ET Feitosa IMPSS de Oliveira RG: Ketamine does not enhance the quality of recovery following laparoscopic cholecystectomy: A randomized controlled trial. Acta Anaesthesiol Scand. 2017;61(7):740–8.

    Not in our library10.1111/aas.12919

  86. 86.

    St Pierre M Dunkel M Rutherford A: Does etomidate increase postoperative nausea? A double-blind controlled comparison of etomidate in lipid emulsion with propofol for balanced anaesthesia. Eur J Anaesthesiol. 2000;17(10):634–41.

    Not in our library10.1046/j.1365-2346.2000.00747.x

  87. 87.

    Subramaniam K Subramaniam B Steinbrook RA: Ketamine as adjuvant analgesic to opioids: A quantitative and qualitative systematic review. Anesth Analg. 2004;99(2):482-95, table of contents.

    Not in our library10.1213/01.ane.0000118109.12855.07

  88. 88.

    Li Z Chen Y: Ketamine reduces pain and opioid consumption after total knee arthroplasty: A meta-analysis of randomized controlled studies. Int J Surg. 2019;70:70–83.

    Not in our library10.1016/j.ijsu.2019.08.026

  89. 89.

    da Silva HBG Sousa AM Guimarães GMN: Does previous chemotherapy-induced nausea and vomiting predict postoperative nausea and vomiting? Acta Anaesthesiol Scand. 2015;59(9):1145–53.

    Not in our library10.1111/aas.12552

  90. 90.

    Laufenberg-Feldmann R Müller M Ferner M: Is 'Anxiety Sensitivity' Predictive of Postoperative Nausea and Vomiting?: A Prospective Observational Study. Eur J Anaesthesiol. 2019;36(5):369–74.

    Not in our library10.1097/eja.0000000000000979

  91. 91.

    Odom-Forren J Hall LA Fetzer SJ: Psychometric Properties of the Ambulatory Surgery Index of Nausea, Vomiting, and Retching. J Nurs Meas. 2016;24(3):454–64.

    Not in our library10.1891/1061-3749.24.3.454

  92. 92.

    Alli A Omar S Tsang S: The effect of ethnicity on the incidence of postoperative nausea and vomiting in moderate to high risk patients undergoing general anesthesia in south africa: a controlled observational study. Middle East J Anaesthesiol. 2017;24(2):119–29.

    Not in our library

  93. 93.

    Kong Y Yan T Gong S: Opioid receptor mu 1 (OPRM1) A118G polymorphism (rs1799971) and postoperative nausea and vomiting. Am J Transl Res. 2018;10(9):2764–80.

    Not in our library

  94. 94.

    López-Morales P Flores-Funes D Sánchez-Migallón EG: Genetic Factors Associated with Postoperative Nausea and Vomiting: A Systematic Review. J Gastrointest Surg. 2018;22(9):1645–51.

    Not in our library10.1007/s11605-018-3788-8

  95. 95.

    Klenke S de Vries GJ Schiefer L: CHRM3 rs2165870 polymorphism is independently associated with postoperative nausea and vomiting, but combined prophylaxis is effective. Br J Anaesth. 2018;121(1):58–65.

    Not in our library10.1016/j.bja.2018.02.025

  96. 96.

    Song JW Shim JK Choi SH: Comparison of Ramosetron and Palonosetron for Preventing Nausea and Vomiting after Spinal Surgery: Association With ABCB1 Polymorphisms. J Neurosurg Anesthesiol. 2017;29(4):406–14.

    Not in our library10.1097/ana.0000000000000361

  97. 97.

    Niewiński P Wojciechowski R Śliwiński M: CYP2D6 basic genotyping as a potential tool to improve the antiemetic efficacy of ondansetron in prophylaxis of postoperative nausea and vomiting. Adv Clin Exp Med. 2018;27(11):1499–503.

    Not in our library10.17219/acem/69451

  98. 98.

    Candiotti KA Birnbach DJ Lubarsky DA: The impact of pharmacogenomics on postoperative nausea and vomiting: Do CYP2D6 allele copy number and polymorphisms affect the success or failure of ondansetron prophylaxis? Anesthesiology. 2005;102(3):543–9.

    Not in our library10.1097/00000542-200503000-00011

  99. 99.

    Canpolat D Dogruel F Gönen Z: The role of platelet count, mean platelet volume, and the mean platelet volume/platelet count ratio in predicting postoperative vomiting in children after deep sedation. Saudi Med J. 2016;37(10):1082–8.

    Not in our library10.15537/smj.2016.10.14903

  100. 100.

    Arpaci AH Işik B Ilhan E: Association of Postoperative Nausea and Vomiting Incidence With Neutrophil-Lymphocyte Ratio in Ambulatory Maxillofacial Surgery. J Oral Maxillofac Surg. 2017;75(7):1367–71.

    Not in our library10.1016/j.joms.2016.12.036

  101. 101.

    Charbit B Albaladejo P Funck-Brentano C: Prolongation of QTc Interval after Postoperative Nausea and Vomiting Treatment by Droperidol or Ondansetron. Anesthesiology. 2005;102(6):1094–100.

    Not in our library10.1097/00000542-200506000-00006

  102. 102.

    Krammes SK Jacobs T Clark JM: Effect of Intravenous Ondansetron on the QT Interval of Patients' Electrocardiograms. Pediatr Emerg Care. 2018;34(1):38–41.

    Not in our library10.1097/pec.0000000000000757

  103. 103.

    Apfel CC Läärä E Koivuranta M: A simplified risk score for predicting postoperative nausea and vomiting: Conclusions from cross-validations between two centers. Anesthesiology. 1999;91(3):693–700.

    Not in our library10.1097/00000542-199909000-00022

  104. 104.

    Apfel CC Kranke P Eberhart LHJ: Comparison of surgical site and patient's history with a simplified risk score for the prediction of postoperative nausea and vomiting. Anaesthesia. 2004;59(11):1078–82.

    Not in our library10.1111/j.1365-2044.2004.03875.x

  105. 105.

    Biedler A Wermelt J Kunitz O: A risk adapted approach reduces the overall institutional incidence of postoperative nausea and vomiting. Can J Anaesth. 2004;51(1):13–9.

    Not in our library10.1007/bf03018540

  106. 106.

    Smith CA Ruth-Sahd L: Reducing the Incidence of Postoperative Nausea and Vomiting Begins With Risk Screening: An Evaluation of the Evidence. J Perianesth Nurs. 2016;31(2):158–71.

    Not in our library10.1016/j.jopan.2015.03.011

  107. 107.

    Wiesmann T Kranke P Eberhart L: Postoperative nausea and vomiting - a narrative review of pathophysiology, pharmacotherapy and clinical management strategies. Expert Opin Pharmacother. 2015;16(7):1069–77.

    Not in our library10.1517/14656566.2015.1033398

  108. 108.

    Kolodzie K Apfel CC: Nausea and vomiting after office-based anesthesia. Curr Opin Anaesthesiol. 2009;22(4):532–8.

    Not in our library10.1097/aco.0b013e32832dba81

  109. 109.

    Chinnappa V Chung F: Post-discharge nausea and vomiting: An overlooked aspect of ambulatory anesthesia? Can J Anaesth. 2008;55(9):565–71.

    Not in our library10.1007/bf03021429

  110. 110.

    Apfel CC Philip BK Cakmakkaya OS: Who Is at Risk for Postdischarge Nausea and Vomiting after Ambulatory Surgery? Anesthesiology. 2012;117(3):475–86.

    Not in our library10.1097/aln.0b013e318267ef31

  111. 111.

    White PF Zhao M Tang J: Use of a disposable acupressure device as part of a multimodal antiemetic strategy for reducing postoperative nausea and vomiting. Anesth Analg. 2012;115(1):31–7.

    Not in our library10.1213/ane.0b013e3182536f27

  112. 112.

    Coloma M White PF Ogunnaike BO: Comparison of Acustimulation and Ondansetron for the Treatment of Established Postoperative Nausea and Vomiting. Anesthesiology. 2002;97(6):1387–92.

    Not in our library10.1097/00000542-200212000-00009

  113. 113.

    White PF Issioui T Hu J: Comparative efficacy of acustimulation (ReliefBand) versus ondansetron (Zofran) in combination with droperidol for preventing nausea and vomiting. Anesthesiology. 2002;97(5):1075–81.

    Not in our library10.1097/00000542-200211000-00008

  114. 114.

    Odom-Forren J Rayens MK Gokun Y: The Relationship of Pain and Nausea in Postoperative Patients for 1 Week After Ambulatory Surgery. Clin J Pain. 2015;31(10):845–51.

    Not in our library10.1097/ajp.0000000000000170

  115. 115.

    Odom-Forren J Jalota L Moser DK: Incidence and predictors of postdischarge nausea and vomiting in a 7-day population. J Clin Anesth. 2013;25(7):551–9.

    Not in our library10.1016/j.jclinane.2013.05.008

  116. 116.

    Bergese SD Puente EG Antor MA: A Prospective, Randomized, Double-Blinded, Double-Dummy Pilot Study to Assess the Preemptive Effect of Triple Therapy with Aprepitant, Dexamethasone, and Promethazine versus Ondansetron, Dexamethasone and Promethazine on Reducing the Incidence of Postoperative Nausea and Vomiting Experienced by Patients Undergoing Craniotomy Under General Anesthesia. Front Med (Lausanne). 2016;3:29.

    Not in our library10.3389/fmed.2016.00029

  117. 117.

    Imani F Zafarghandi-Motlagh M: Postoperative nausea and vomiting in patients undergoing laparoscopy. J Minim Invasive Surg Sci. 2013;2:138–43.

    Not in our library

  118. 118.

    Ryu JH Lee JE Lim YJ: A prospective, randomized, double-blind, and multicenter trial of prophylactic effects of ramosetronon postoperative nausea and vomiting (PONV) after craniotomy: Comparison with ondansetron. BMC Anesthesiol. 2014;14:63.

    Not in our library10.1186/1471-2253-14-63

  119. 119.

    Alimian M Imani F Faiz SHR: Effect of oral pregabalin premedication on post-operative pain in laparoscopic gastric bypass surgery. Anesth Pain Med. 2012;2(1):12–6.

    Not in our library10.5812/aapm.4300

  120. 120.

    Lee A Chan SKC Fan LTY: Stimulation of the wrist acupuncture point PC6 for preventing postoperative nausea and vomiting. Cochrane Database Syst Rev. 2015;2015(11):CD003281.

    Not in our library10.1002/14651858.cd003281.pub4

  121. 121.

    Manahan MA Basdag B Kalmar CL: Risk of severe and refractory postoperative nausea and vomiting in patients undergoing diep flap breast reconstruction. Microsurgery. 2014;34(2):112–21.

    Not in our library10.1002/micr.22155

  122. 122.

    Apfel CC Korttila K Abdalla M: A Factorial Trial of Six Interventions for the Prevention of Postoperative Nausea and Vomiting. N Engl J Med. 2004;350(24):2441–51.

    Not in our library10.1056/nejmoa032196

  123. 123.

    Tang J Wang B White PF: The effect of timing of ondansetron administration on its efficacy, cost-effectiveness, and cost-benefit as a prophylactic antiemetic in the ambulatory setting. Anesth Analg. 1998;86(2):274–82.

    Not in our library10.1097/00000539-199802000-00010

  124. 124.

    White PF Tang J Hamza MA: The use of oral granisetron versus intravenous ondansetron for antiemetic prophylaxis in patients undergoing laparoscopic surgery: The effect on emetic symptoms and quality of recovery. Anesth Analg. 2006;102(5):1387–93.

    Not in our library10.1213/01.ane.0000208967.94601.cd

  125. 125.

    Kamali A Ahmadi L Shokrpour M: Investigation of Ondansetron, Haloperidol, and Dexmedetomidine Efficacy for Prevention of Postoperative Nausea and Vomiting In Patients with Abdominal Hysterectomy. Open Access Maced J Med Sci. 2018;6(9):1659–63.

    Not in our library10.3889/oamjms.2018.366

  126. 126.

    Isazadehfar K Entezariasl M Shahbazzadegan B: The Comparative Study of Ondansetron and Metoclopramide Effects in Reducing Nausea and Vomiting After Laparoscopic Cholecystectomy. Acta Med Iran. 2017;55(4):254–8.

    Not in our library

  127. 127.

    Bai B Pei LJ Zhang YL: Adding Ondansetron in Morphine Intravenous Analgesia Pump for Prevention of Postoperative Nausea and Vomiting in Women. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2018;40(3):373–7.

    Not in our library10.3881/j.issn.1000-503x.2018.03.013

  128. 128.

    Pazoki S Modir H Kamali A: Ondansetron 8 mg and 4 mg with normal saline against post-operative headache and nausea/vomiting after spinal anesthesia: A randomized double-blind trial. Med Gas Res. 2018;8(2):48–53.

    Not in our library10.4103/2045-9912.235125

  129. 129.

    Koyuncu O Leung S You J: The effect of ondansetron on analgesic efficacy of acetaminophen after hysterectomy: A randomized double blinded placebo controlled trial. J Clin Anesth. 2017;40:78–83.

    Not in our library10.1016/j.jclinane.2017.03.049

  130. 130.

    Zhu M Zhou C Huang B: Granisetron plus dexamethasone for prevention of postoperative nausea and vomiting in patients undergoing laparoscopic surgery: A meta-analysis. J Int Med Res. 2017;45(3):904–11.

    Not in our library10.1177/0300060517703276

  131. 131.

    Lee WS Lee KB Lim S: Comparison of palonosetron, granisetron, and ramosetron for the prevention of postoperative nausea and vomiting after laparoscopic gynecologic surgery: A prospective randomized trial. BMC Anesthesiol. 2015;15:121.

    Not in our library10.1186/s12871-015-0102-0

  132. 132.

    Tahir S Mir AA Hameed A: Comparison of Palonosetron with Granisetron for Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Abdominal Surgery. Anesth Essays Res. 2018;12(3):636–43.

    Not in our library10.4103/aer.aer_84_18

  133. 133.

    White PF: Ambulatory Anesthesia and Surgery. London,WB Saunders,1997;442.

    Not in our library

  134. 134.

    Hahm TS Ko JS Choi SJ: Comparison of the prophylactic anti-emetic efficacy of ramosetron and ondansetron in patients at high-risk for postoperative nausea and vomiting after total knee replacement. Anaesthesia. 2010;65(5):500–4.

    Not in our library10.1111/j.1365-2044.2010.06310.x

  135. 135.

    Joo J Park S Park HJ: Ramosetron versus ondansetron for postoperative nausea and vomiting in strabismus surgery patients. BMC Anesthesiol. 2016;16(1):41.

    Not in our library10.1186/s12871-016-0210-5

  136. 136.

    Gao C Li B Xu L: Efficacy and safety of ramosetron versus ondansetron for postoperative nausea and vomiting after general anesthesia: A meta-analysis of randomized clinical trials. Drug Des Devel Ther. 2015;9:2343–50.

    Not in our library10.2147/dddt.s80407

  137. 137.

    Yokoi A Mihara T Ka K: Comparative efficacy of ramosetron and ondansetron in preventing postoperative nausea and vomiting: An updated systematic review and meta-analysis with trial sequential analysis. PLoS One. 2017;12:e0186006.

    Not in our library10.1371/journal.pone.0186006

  138. 138.

    Choi YS Sohn HM Do SH: Comparison of ramosetron and ondansetron for the treatment of established postoperative nausea and vomiting after laparoscopic surgery: A prospective, randomized, double-blinded multicenter trial. Ther Clin Risk Manag. 2018;14:601–6.

    Not in our library10.2147/tcrm.s159211

  139. 139.

    Pinsornsak P Teeyaphudit M Ruetiwarangkoon C: Comparison of Ramosetron With Ondansetron for Prevention of Intrathecal Morphine-Induced Nausea and Vomiting After Primary Total Knee Arthroplasty: A Randomized Control Trial. J Arthroplasty. 2017;32(3):1040–3.

    Not in our library10.1016/j.arth.2016.09.013

  140. 140.

    Park HE Kim MK Kang WK: Efficacy and Safety of Ramosetron Injection for Nausea and Vomiting in Colorectal-Cancer Patients Undergoing a Laparoscopic Colectomy: A Randomized, Double-Blind, Comparative Study. Ann Coloproctol. 2018;34(1):36–41.

    Not in our library10.3393/ac.2018.34.1.36

  141. 141.

    Lee B Kim K Suh DH: Efficacy of Single-dose and 2-dose Intravenous Administration of Ramosetron in Preventing Postoperative Nausea and Vomiting After Laparoscopic Gynecologic Operation: A Randomized, Double-blind, Placebo-controlled, Phase 2 Trial. Surg Laparosc Endosc Percutan Tech. 2017;27(3):183–8.

    Not in our library10.1097/sle.0000000000000399

  142. 142.

    Wangnamthip S Chinachoti T Amornyotin S: A Randomized Placebo-Controlled Trial of Oral Ramosetron for Prevention of Post Operative Nausea and Vomiting after Intrathecal Morphine in Patients Undergoing Gynecological Surgery. J Med Assoc Thai. 2016;99(5):455–61.

    Not in our library

  143. 143.

    Singh PM Borle A Gouda D: Efficacy of palonosetron in postoperative nausea and vomiting (PONV)-a meta-analysis. J Clin Anesth. 2016;34:459–82.

    Not in our library10.1016/j.jclinane.2016.05.018

  144. 144.

    Ahn EJ Choi GJ Kang H: Comparison of Ramosetron with Palonosetron for Prevention of Postoperative Nausea and Vomiting in Patients Receiving Opioid-Based Intravenous Patient-Controlled Analgesia after Gynecological Laparoscopy. Biomed Res Int. 2017;2017:9341738.

    Not in our library10.1155/2017/9341738

  145. 145.

    Carvalho Braga EL Figueiredo NV Barrucand L: Use of palonosetron and ondansetron in the prophylaxis of postoperative nausea and vomiting in women 60 years of age or older undergoing laparoscopic cholecystectomy: A randomised double-blind study. Eur J Anaesthesiol. 2019;36(3):241–2.

    Not in our library10.1097/eja.0000000000000932

  146. 146.
    Effects of palonosetron and ondansetron on preventing nausea and vomiting after laparoscopic surgery · 2018
    Not checked
  147. 147.

    Reddy G Manjusruthi B Jyothsna G: Postoperative nausea and vomiting prophylaxis: A comparative study of ramosetron and palonosetron in patients undergoing laparoscopic cholecystectomy - A prospective randomized trial. Anesth Essays Res. 2019;13:68–72.

    Not in our library10.4103/aer.aer_192_18

  148. 148.

    Kim MS Park JH Choi YS: Efficacy of Palonosetron vs. Ramosetron for the Prevention of Postoperative Nausea and Vomiting: A Meta-Analysis of Randomized Controlled Trials. Yonsei Med J. 2017;58(4):848–58.

    Not in our library10.3349/ymj.2017.58.4.848

  149. 149.

    Wang JJ Ho ST Lee SC: The use of dexamethasone for preventing postoperative nausea and vomiting in females undergoing thyroidectomy: A dose-ranging study. Anesth Analg. 2000;91(6):1404–7.

    Not in our library10.1097/00000539-200012000-00019

  150. 150.

    Maitra S Som A Baidya DK: Comparison of Ondansetron and Dexamethasone for Prophylaxis of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Surgeries: A Meta-Analysis of Randomized Controlled Trials. Anesthesiol Res Pract. 2016;2016:7089454.

    Not in our library10.1155/2016/7089454

  151. 151.

    Parthasarathy P Babu K Raghavendra Rao RS: The Effect of Single-dose Intravenous Dexamethasone on Postoperative Pain and Postoperative Nausea and Vomiting in Patients Undergoing Surgery under Spinal Anesthesia: A Double-blind Randomized Clinical Study. Anesth Essays Res. 2018;12(2):313–7.

    Not in our library10.4103/aer.aer_159_17

  152. 152.

    Ormel G Romundstad L Lambert-Jensen P: Dexamethasone has additive effect when combined with ondansetron and droperidol for treatment of established PONV. Acta Anaesthesiol Scand. 2011;55(10):1196–205.

    Not in our library10.1111/j.1399-6576.2011.02536.x

  153. 153.

    Murphy GS Szokol JW Greenberg SB: Preoperative dexamethasone enhances quality of recovery after laparoscopic cholecystectomy: Effect on in-hospital and postdischarge recovery outcomes. Anesthesiology. 2011;114(4):882–90.

    Not in our library10.1097/aln.0b013e3181ec642e

  154. 154.

    Ismail EA Bakri MH Abd-Elshafy SK: Dexamethasone alone versus in combination with intra-operative super-hydration for postoperative nausea and vomiting prophylaxis in female patients undergoing laparoscopic cholecystectomy: A randomized clinical trial. Korean J Anesthesiol. 2017;70(5):535–541.

    Not in our library10.4097/kjae.2017.70.5.535

  155. 155.

    Awad K Ahmed H Abushouk AI: Dexamethasone combined with other antiemetics versus single antiemetics for prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy: An updated systematic review and meta-analysis. Int J Surg. 2016;36(Pt A):152–63.

    Not in our library10.1016/j.ijsu.2016.10.034

  156. 156.

    Kumar A Patodia M Pandove P: A randomized, placebo-controlled study evaluating preventive role of ondansetron, dexamethasone and ondansetron plus dexamethasone for postoperative nausea and vomiting (PONV) in patients undergoing laparoscopic cholecystectomy. Journal International Medical Sciences Academy 2013;26(4):217–8. Reference Source

    Not in our library

  157. 157.

    Coloma M White PF Markowitz SD: Dexamethasone in Combination With Dolasetron for Prophylaxis in the Ambulatory Setting: Effect on Outcome After Laparoscopic Cholecystectomy. Anesthesiology. 2002;96(6):1346–50.

    Not in our library10.1097/00000542-200206000-00013

  158. 158.

    Amer M Uddin S Rasheed F: Comparison of use of metoclopramide alone and in combination with dexamethasone for prevention of postoperative nausea and vomiting in laparoscopic cholecystectomy. Pak J Med Health Sci. 2012;6(3):626–8. Reference Source

    Not in our library

  159. 159.

    Jo YY Lee JW Shim JK: Ramosetron, dexamethasone, and their combination for the prevention of postoperative nausea and vomiting in women undergoing laparoscopic cholecystectomy. Surg Endosc. 2012;26(8):2306–11.

    Not in our library10.1007/s00464-012-2180-0

  160. 160.

    Ahsan K Abbas N Naqvi SMN: Comparison of efficacy of ondansetron and dexamethasone combination and ondansetron alone in preventing postoperative nausea and vomiting after laparoscopic cholecystectomy. J Pak Med Assoc. 2014;64(3):242–6.

    Not in our library

  161. 161.

    Ko-Iam W Sandhu T Paiboonworachat S: Metoclopramide, versus its combination with dexamethasone in the prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy: A double-blind randomized controlled trial. J Med Assoc Thai. 2015;98(3):265–72.

    Not in our library

  162. 162.

    Bala I Bharti N Murugesan S: Comparison of palonosetron with palonosetron-dexamethasone combination for prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy. Minerva Anestesiol. 2014;80(7):779–84.

    Not in our library

  163. 163.

    Alia I Gillani M Hanif A: Comparison of ondansetron and combination of ondansetron and dexamethasone for prevention of post-operative nausea and vomiting in patients undergoing elective laparoscopic cholecystectomy. Pak J Med Health Sci. 2015;9(4):1387–89. Reference Source

    Not in our library

  164. 164.

    Gupta R Srivastava S Dhiraaj S: Minimum effective dose of dexamethasone in combination with midazolam as prophylaxis against postoperative nausea and vomiting after laparoscopic cholecystectomy. Anesth Essays Res. 2018;12(2):396–401.

    Not in our library10.4103/aer.aer_19_18

  165. 165.

    Cortés-Flores AO Jiménez-Tornero J Morgan-Villela G: Effects of preoperative dexamethasone on postoperative pain, nausea, vomiting and respiratory function in women undergoing conservative breast surgery for cancer: Results of a controlled clinical trial. Eur J Cancer Care (Engl). 2018;27(1).

    Not in our library10.1111/ecc.12686

  166. 166.

    DREAMS Trial Collaborators and West Midlands Research Collaborative: Dexamethasone versus standard treatment for postoperative nausea and vomiting in gastrointestinal surgery: Randomised controlled trial (DREAMS Trial). BMJ. 2017;357:j1455.

    Not in our library10.1136/bmj.j1455

  167. 167.

    Xu B Ma J Huang Q: Two doses of low-dose perioperative dexamethasone improve the clinical outcome after total knee arthroplasty: A randomized controlled study. Knee Surg Sports Traumatol Arthrosc. 2018;26(5):1549–56.

    Not in our library10.1007/s00167-017-4506-x

  168. 168.

    Fan Z Ma J Kuang M: The efficacy of dexamethasone reducing postoperative pain and emesis after total knee arthroplasty: A systematic review and meta-analysis. Int J Surg. 2018;52:149–55.

    Not in our library10.1016/j.ijsu.2018.02.043

  169. 169.

    Ismail EA Abo Elfadl GM Bahloul M: Comparison of intraperitoneal versus intravenous dexamethasone on postoperative nausea and vomiting after gynecological laparoscopy: A randomized clinical trial. Korean J Anesthesiol. 2019;72(1):47–52.

    Not in our library10.4097/kja.d.18.00132

  170. 170.

    Seki H Wakamiya R Ihara N: The Effect of Dexamethasone on Postoperative Nausea and Vomiting in Posterior Correction and Fusion Surgery for Adolescent Idiopathic Scoliosis. Masui. 2017;66(3):298–302.

    Not in our library

  171. 171.

    Sane S Hasanlui MV Abbasivash R: Comparing the effect of intravenous dexamethasone, intravenous ondansetron, and their combination on nausea and vomiting in cesarean section with spinal anesthesia. Adv Biomed Res. 2015;4:230.

    Not in our library10.4103/2277-9175.167030

  172. 172.

    Wakamiya R Seki H Ideno S: Effects of prophylactic dexamethasone on postoperative nausea and vomiting in scoliosis correction surgery: A double-blind, randomized, placebo-controlled clinical trial. Sci Rep. 2019;9(1):2119.

    Not in our library10.1038/s41598-019-38764-8

  173. 173.

    Reibaldi M Fallico M Longo A: Efficacy of Three Different Prophylactic Treatments for Postoperative Nausea and Vomiting after Vitrectomy: A Randomized Clinical Trial. J Clin Med. 2019;8(3):391.

    Not in our library10.3390/jcm8030391

  174. 174.

    Cho E Kim DH Shin S: Efficacy of Palonosetron-Dexamethasone Combination Versus Palonosetron Alone for Preventing Nausea and Vomiting Related to Opioid-Based Analgesia: A Prospective, Randomized, Double-blind Trial. Int J Med Sci. 2018;15(10):961–8.

    Not in our library10.7150/ijms.24230

  175. 175.

    Frelich M Divák J Vodička V: Dexamethasone Reduces the Incidence of Postoperative Nausea and Vomiting in Children Undergoing Endoscopic Adenoidectomy under General Anesthesia Without Increasing the Risk of Postoperative Hemorrhage. Med Sci Monit. 2018;24:8430–8.

    Not in our library10.12659/msm.911231

  176. 176.

    Sayed JA Riad MAF Ali MOM: Comparison of dexamethasone or intravenous fluids or combination of both on postoperative nausea, vomiting and pain in pediatric strabismus surgery. J Clin Anesth. 2016;34:136–42.

    Not in our library10.1016/j.jclinane.2016.03.049

  177. 177.

    Haapanen A Thorén H Törnwall J: Postoperative nausea and vomiting in facial fracture patients: A Randomized and controlled trial on the effect of dexamethasone. Int J Oral Maxillofac Surg. 2017;46(10):1267–70.

    Not in our library10.1016/j.ijom.2017.03.026

  178. 178.

    Kleif J Kirkegaard A Vilandt J: Randomized clinical trial of preoperative dexamethasone on postoperative nausea and vomiting after laparoscopy for suspected appendicitis. Br J Surg. 2017;104(4):384–92.

    Not in our library10.1002/bjs.10418

  179. 179.

    Thongrong C Chullabodhi P Kasemsiri P: Effects of Intraoperative Dexamethasone and Ondansetron on Postoperative Nausea and Vomiting in Microvascular Decompression Surgery: A Randomized Controlled Study. Anesthesiology Research and Practice. 2018;2018:6297362.

    Not in our library10.1155/2018/6297362

  180. 180.

    Singh PM Borle A Panwar R: Perioperative antiemetic efficacy of dexamethasone versus 5-HT3 receptor antagonists: A meta-analysis and trial sequential analysis of randomized controlled trials. Eur J Clin Pharmacol. 2018;74(10):1201–14.

    Not in our library10.1007/s00228-018-2495-4

  181. 181.

    Wasfie T Tabatabai A Hedni R: Effect of intra-operative single dose of dexamethasone for control of post-operative nausea and vomiting on the control of glucose levels in diabetic patients. Am J Surg. 2018;215(3):488–90.

    Not in our library10.1016/j.amjsurg.2017.11.019

  182. 182.

    Aasboe V Raeder JC Groegaard B: Betamethasone Reduces Postoperative Pain and Nausea After Ambulatory Surgery. Anesth Analg. 1998;87(2):319–23.

    Not in our library10.1097/00000539-199808000-00015

  183. 183.

    Thagaard KS Jensen HH Raeder J: Analgesic and antiemetic effect of ketorolac vs. betamethasone or dexamethasone after ambulatory surgery. Acta Anaesthesiol Scand. 2007;51(3):271–7.

    Not in our library10.1111/j.1399-6576.2006.01240.x

  184. 184.

    Olanders KJ Lundgren GAE Johansson AMG: Betamethasone in prevention of postoperative nausea and vomiting following breast surgery. J Clin Anesth. 2014;26(6):461–5.

    Not in our library10.1016/j.jclinane.2014.02.006

  185. 185.

    Champion S Zieger L Hemery C: Prophylaxis of postoperative nausea and vomiting after cardiac surgery in high-risk patients: A randomized controlled study. Ann Card Anaesth. 2018;21(1):8–14.

    Not in our library10.4103/aca.aca_122_17

  186. 186.

    Nordin L Nordlund A Lindqvist A: Corticosteroids or Not for Postoperative Nausea: A Double-Blinded Randomized Study. J Gastrointest Surg. 2016;20(8):1517–22.

    Not in our library10.1007/s11605-016-3166-3

  187. 187.

    Liu M Zhang H Du BX: Neurokinin-1 Receptor Antagonists in Preventing Postoperative Nausea and Vomiting: A Systematic Review and Meta-Analysis. Medicine (Baltimore). 2015;94(19):e762.

    Not in our library10.1097/md.0000000000000762

  188. 188.

    Gesztesi Z Scuderi PE White PF: Substance P (Neurokinin-1) antagonist prevents postoperative vomiting after abdominal hysterectomy procedures. Anesthesiology. 2000;93(4):931–7.

    Not in our library10.1097/00000542-200010000-00009

  189. 189.

    Diemunsch P Gan TJ Philip BK: Single-dose aprepitant vs ondansetron for the prevention of postoperative nausea and vomiting: A randomized, double-blind Phase III trial in patients undergoing open abdominal surgery. Br J Anaesth. 2007;99(2):202–11.

    Not in our library10.1093/bja/aem133

  190. 190.

    Milnes V Gonzalez A Amos V: Aprepitant: A New Modality for the Prevention of Postoperative Nausea and Vomiting: An Evidence-Based Review. J Perianesth Nurs. 2015;30(5):406–17.

    Not in our library10.1016/j.jopan.2014.11.013

  191. 191.

    Gan TJ Apfel CC Kovac A: A Randomized, Double-Blind Comparison of the NK1 Antagonist, Aprepitant, Versus Ondansetron for the Prevention of Postoperative Nausea and Vomiting. Anesth Analg. 2007;104(5):1082–9.

    Not in our library10.1213/01.ane.0000263277.35140.a3

  192. 192.

    Emami H Hematti S Saeidian SM: The efficacy of combination of ondansetron and aprepitant on preventing the radiotherapy-induced nausea and vomiting. J Res Med Sci. 2015;20(4):329–33.

    Not in our library

  193. 193.

    Bilgen S Kizilcik N Haliloglu M: Effect of the Dexamethasone-Ondansetron Combination Versus Dexamethasone-Aprepitant Combination to Prevent Postoperative Nausea and Vomiting. Turk J Anaesth Reanim. 2018;46(5):373–80.

    Not in our library10.5152/tjar.2018.53179

  194. 194.

    Habib AS Keifer JC Borel CO: A comparison of the combination of aprepitant and dexamethasone versus the combination of ondansetron and dexamethasone for the prevention of postoperative nausea and vomiting in patients undergoing craniotomy. Anesth Analg. 2011;112(4):813–8.

    Not in our library10.1213/ane.0b013e3181ff47e2

  195. 195.

    Jeyabalan S Thampi S Karuppusami R: Comparing the efficacy of aprepitant and ondansetron for the prevention of postoperative nausea and vomiting (PONV): A double blinded, randomised control trial in patients undergoing breast and thyroid surgeries. Indian J Anaesth. 2019;63(4):289–294.

    Not in our library10.4103/ija.ija_724_18

  196. 196.
    Aprepitant in combination with palonosetron for the prevention of postoperative nausea and vomiting in female patients using intravenous patient-controlled analgesia · 2018
    Not checked
  197. 197.

    Salman FT DiCristina C Chain A: Pharmacokinetics and pharmacodynamics of aprepitant for the prevention of postoperative nausea and vomiting in pediatric subjects. J Pediatr Surg. 2019;54(7):1384–90.

    Not in our library10.1016/j.jpedsurg.2018.09.006

  198. 198.

    Atsuta J Inoue S Tanaka Y: Fosaprepitant versus droperidol for prevention of PONV in craniotomy: A randomized double-blind study. J Anesth. 2017;31(1):82–8.

    Not in our library10.1007/s00540-016-2267-1

  199. 199.

    Soga T Kume K Kakuta N: Fosaprepitant versus ondansetron for the prevention of postoperative nausea and vomiting in patients who undergo gynecologic abdominal surgery with patient-controlled epidural analgesia: A prospective, randomized, double-blind study. J Anesth. 2015;29(5):696–701.

    Not in our library10.1007/s00540-015-2006-z

  200. 200.

    White PF: Droperidol: A cost-effective antiemetic for over thirty years. Anesth Analg. 2002;95(4):789–90.

    Not in our library10.1097/00000539-200210000-00001

  201. 201.

    Fortney JT Gan TJ Graczyk S: A Comparison of the Efficacy, Safety, and Patient Satisfaction of Ondansetron Versus Droperidol as Antiemetics for Elective Outpatient Surgical Procedures. Anesth Analg. 1998;86(4):731–8.

    Not in our library10.1097/00000539-199804000-00011

  202. 202.

    Hill RP Lubarsky DA Phillips-Bute B: Cost-effectiveness of prophylactic antiemetic therapy with ondansetron, droperidol, or placebo. Anesthesiology. 2000;92(4):958–67.

    Not in our library10.1097/00000542-200004000-00012

  203. 203.

    White PF: Prevention of postoperative nausea and vomiting--a multimodal solution to a persistent problem. N Engl J Med. 2004;350(24):2511–2.

    Not in our library10.1056/nejme048099

  204. 204.

    Tricco AC Soobiah C Blondal E: Comparative safety of serotonin (5-HT 3) receptor antagonists in patients undergoing surgery: A systematic review and network meta-analysis. BMC Med. 2015;13:142.

    Not in our library10.1186/s12916-015-0379-3

  205. 205.

    Flubacher P Fournier N Cherpillod J: A randomised controlled trial of placebo, droperidol or ondansetron to prevent nausea and vomiting after tonsillectomy in children receiving dexamethasone. Anaesthesia. 2017;72(7):859–63.

    Not in our library10.1111/anae.13907

  206. 206.

    Charton A Greib N Ruimy A: Incidence of akathisia after postoperative nausea and vomiting prophylaxis with droperidol and ondansetron in outpatient surgery: A multicentre controlled randomised trial. Eur J Anaesthesiol. 2018;35(12):966–71.

    Not in our library10.1097/eja.0000000000000821

  207. 207.

    Bourdaud N François C Jacqmarcq O: Addition of droperidol to prophylactic ondansetron and dexamethasone in children at high risk for postoperative vomiting. A randomized, controlled, double-blind study. Br J Anaesth. 2017;118(6):918–23.

    Not in our library10.1093/bja/aex099

  208. 208.

    Singh PM Borle A Makkar JK: Haloperidol Versus 5-HT 3 Receptor Antagonists for Postoperative Vomiting and QTc Prolongation: A Noninferiority Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials. J Clin Pharmacol. 2018;58(2):131–43.

    Not in our library10.1002/jcph.999

  209. 209.

    Brettner F Janitza S Prüll K: Gender-Specific Differences in Low-Dose Haloperidol Response for Prevention of Postoperative Nausea and Vomiting: A Register-Based Cohort Study. PLoS One. 2016;11(1):e0146746.

    Not in our library10.1371/journal.pone.0146746

  210. 210.

    Mishriky BM Habib AS: Metoclopramide for nausea and vomiting prophylaxis during and after Caesarean delivery: A systematic review and meta-analysis. Br J Anaesth. 2012;108(3):374–83.

    Not in our library10.1093/bja/aer509

  211. 211.

    Habib AS Kranke P Bergese SD: Amisulpride for the Rescue Treatment of Postoperative Nausea or Vomiting in Patients Failing Prophylaxis: A Randomized, Placebo-controlled Phase III Trial. Anesthesiology. 2019;130(2):203–12.

    Not in our library10.1097/aln.0000000000002509

  212. 212.

    Candiotti KA Kranke P Bergese SD: Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Amisulpride as Treatment of Established Postoperative Nausea and Vomiting in Patients Who Have Had No Prior Prophylaxis. Anesth Analg. 2019;128(6):1098–105.

    Not in our library10.1213/ane.0000000000003733

  213. 213.

    Gan TJ Kranke P Minkowitz HS: Intravenous Amisulpride for the Prevention of Postoperative Nausea and Vomiting: Two Concurrent, Randomized, Double-blind, Placebo-controlled Trials. Anesthesiology. 2017;126(2):268–75.

    Not in our library10.1097/aln.0000000000001458

  214. 214.

    Kranke P Bergese SD Minkowitz HS: Amisulpride Prevents Postoperative Nausea and Vomiting in Patients at High Risk: A Randomized, Double-blind, Placebo-controlled Trial. Anesthesiology. 2018;128(6):1099–106.

    Not in our library10.1097/aln.0000000000002133

  215. 215.

    White PF Tang J Song D: Transdermal scopolamine: An alternative to ondansetron and droperidol for the prevention of postoperative and postdischarge emetic symptoms. Anesth Analg. 2007;104(1):92–6.

    Not in our library10.1213/01.ane.0000250364.91567.72

  216. 216.

    Apfel CC Zhang K George E: Transdermal scopolamine for the prevention of postoperative nausea and vomiting: A systematic review and meta-analysis. Clin Ther. 2010;32(12):1987–2002.

    Not in our library10.1016/j.clinthera.2010.11.014

  217. 217.

    Pergolizzi JV Philip BK Leslie JB: Perspectives on transdermal scopolamine for the treatment of postoperative nausea and vomiting. J Clin Anesth. 2012;24(4):334–45.

    Not in our library10.1016/j.jclinane.2011.07.019

  218. 218.

    Kassel L Nelson M Shine J: Scopolamine Use in the Perioperative Patient: A Systematic Review. AORN J. 2018;108(3):287–95.

    Not in our library10.1002/aorn.12336

  219. 219.

    Cangemi DJ Kuo B: Practical Perspectives in the Treatment of Nausea and Vomiting. J Clin Gastroenterol. 2019;53(3):170–8.

    Not in our library10.1097/mcg.0000000000001164

  220. 220.
    Dexmedetomidine use during epiduroscopy reduces fentanyl use and postoperative nausea and vomiting: A single-center retrospective study · 2018
    Not checked
  221. 221.

    Geng ZY Liu YF Wang SS: Intra-operative Dexmedetomidine Reduces Early Postoperative Nausea but Not Vomiting in Adult Patients After Gynaecological Laparoscopic Surgery: A Randomised Controlled Trial. Eur J Anaesthesiol. 2016;33(10):761–6.

    Not in our library10.1097/eja.0000000000000491

  222. 222.

    Jin S Liang DD Chen C: Dexmedetomidine prevent postoperative nausea and vomiting on patients during general anesthesia: A PRISMA-compliant meta analysis of randomized controlled trials. Medicine (Baltimore). 2017;96(1):e5770.

    Not in our library10.1097/md.0000000000005770

  223. 223.

    Ajori L Nazari L Mazloomfard MM: Effects of gabapentin on postoperative pain, nausea and vomiting after abdominal hysterectomy: A double blind randomized clinical trial. Arch Gynecol Obstet. 2012;285(3):677–82.

    Not in our library10.1007/s00404-011-2023-6

  224. 224.

    Grant MC Lee H Page AJ: The Effect of Preoperative Gabapentin on Postoperative Nausea and Vomiting: A Meta-Analysis. Anesth Analg. 2016;122(4):976–85.

    Not in our library10.1213/ane.0000000000001120

  225. 225.
    Comparative study of preoperative use of oral gabapentin, intravenous dexamethasone and their combination in gynaecological procedure · 2015
    Not checked
  226. 226.

    Tsai KC Yang YL Fan PC: Gabapentin for Postoperative Vomiting in Children Requiring Posterior Fossa Tumor Resection. Pediatr Neonatol. 2015;56(3):351–4.

    Not in our library10.1016/j.pedneo.2013.04.002

  227. 227.

    Grant MC Betz M Hulse M: The Effect of Preoperative Pregabalin on Postoperative Nausea and Vomiting: A Meta-analysis. Anesth Analg. 2016;123(5):1100–7.

    Not in our library10.1213/ane.0000000000001404

  228. 228.

    Wang YM Xia M Shan N: Pregabalin Can Decrease Acute Pain and Postoperative Nausea and Vomiting in Hysterectomy: A Meta-Analysis. Medicine (Baltimore). 2017;96(31):e7714.

    Not in our library10.1097/md.0000000000007714

  229. 229.

    White PF Tufanogullari B Taylor J: The effect of pregabalin on preoperative anxiety and sedation levels: A dose-ranging study. Anesth Analg. 2009;108(4):1140–5.

    Not in our library10.1213/ane.0b013e31818d40ce

  230. 230.

    Kizilcik N Bilgen S Menda F: Comparison of Dexamethasone-Dimenhydrinate and Dexamethasone-Ondansetron in Prevention of Nausea and Vomiting in Postoperative Patients. Aesthetic Plast Surg. 2017;41(1):204–10.

    Not in our library10.1007/s00266-016-0772-0

  231. 231.

    Malamood M Roberts A Kataria R: Mirtazapine for symptom control in refractory gastroparesis. Drug Des Devel Ther. 2017;11:1035–41.

    Not in our library10.2147/dddt.s125743

  232. 232.

    Bhattacharjee D Doleman B Lund J: Mirtazapine for Postoperative Nausea and Vomiting: Systematic Review, Meta-analysis, and Trial Sequential Analysis. J Perianesth Nurs. 2019;34(4):680–90.

    Not in our library10.1016/j.jopan.2018.11.006

  233. 233.

    Heidari SM Saryazdi H Saghaei M: Effect of intravenous midazolam premedication on postoperative nausea and vomiting after cholecystectomy. Acta Anaesthesiol Taiwan. 2004;42(2):77–80.

    Not in our library

  234. 234.

    Jung JS Park JS Kim SO: Prophylactic antiemetic effect of midazolam after middle ear surgery. Otolaryngol Head Neck Surg. 2016;137(5):753–6.

    Not in our library10.1016/j.otohns.2007.07.024

  235. 235.

    Shirdashtzadeh N Eshraghi N Eshraghi A: Comparison of parenteral promethazine versus midazolam effect as a preoperative medication on postoperative nausea and vomiting after appendectomy. Caspian J Intern Med. 2011;2(3):270–3.

    Not in our library

  236. 236.

    Kranke P Eberhart LHJ: Possibilities and limitations in the pharmacological management of postoperative nausea and vomiting. Eur J Anaesthesiol. 2011;28(11):758–65.

    Not in our library10.1097/eja.0b013e32834a4e1e

  237. 237.

    Honarmand A Safavi M Khalili G: Prophylactic administration of haloperidol plus midazolam reduces postoperative nausea and vomiting better than using each drug alone in patients undergoing middle ear surgery. Saudi J Anaesth. 2012;6(2):145–51.

    Not in our library10.4103/1658-354x.97028

  238. 238.

    Kim WJ Kang H Shin HY: Ramosetron, midazolam, and combination of ramosetron and midazolam for prevention of postoperative nausea and vomiting: A prospective, randomized, double-blind study. J Int Med Res. 2013;41(4):1203–13.

    Not in our library10.1177/0300060513485864

  239. 239.

    Park EY Lee SK Kang MH: Comparison of ramosetron with combined ramosetron and midazolam for preventing postoperative nausea and vomiting in patients at high risk following laparoscopic gynaecological surgery. J Int Med Res. 2013;41(3):654–63.

    Not in our library10.1177/0300060513487627

  240. 240.

    Abdelhamid S Kamel M: A prospective controlled study to assess the antiemetic effect of midazolam following intragastric balloon insertion. J Anaesthesiol Clin Pharmacol. 2014;30(3):383–6.

    Not in our library10.4103/0970-9185.137272

  241. 241.

    Grant MC Kim J Page AJ: The Effect of Intravenous Midazolam on Postoperative Nausea and Vomiting: A Meta-Analysis. Anesth Analg. 2016;122(3):656–63.

    Not in our library10.1213/ane.0000000000000941

  242. 242.

    Jabaley CS Gray DW Budhrani GS: Chronic Atypical Antipsychotic Use Is Associated With Reduced Need for Postoperative Nausea and Vomiting Rescue in the Postanesthesia Care Unit: A Propensity-Matched Retrospective Observational Study. Anesth Analg. 2020;130(1):141–50.

    Not in our library10.1213/ane.0000000000003990

  243. 243.

    Kang HY Park SW Lee S: Effect of prophylactic palonosetron and sugammadex on postoperative nausea and vomiting in patients undergoing microvascular decompression under propofol-maintained anesthesia: A retrospective observational study. Medicine (Baltimore). 2018;97(46):e13237.

    Not in our library10.1097/md.0000000000013237

  244. 244.

    Aksoy M İnce İ Ahıskalıoğlu A: Effect of intravenous preoperative versus postoperative paracetamol on postoperative nausea and vomiting in patients undergoing strabismus surgery: A prospective randomized study. Agri. 2018;30(1):1–7.

    Not in our library10.5505/agri.2017.65872

  245. 245.

    Roberts CA Shah-Becker S O'Connell Ferster A: Randomized Prospective Evaluation of Intraoperative Intravenous Acetaminophen in Pediatric Adenotonsillectomy. Otolaryngol Head Neck Surg. 2018;158(2):368–74.

    Not in our library10.1177/0194599817728911

  246. 246.

    Levin DN Dulberg Z Chan AW: A randomized-controlled trial of nabilone for the prevention of acute postoperative nausea and vomiting in elective surgery. Can J Anesth. 2017;64(4):385–95.

    Not in our library10.1007/s12630-017-0814-3

  247. 247.

    Ibrahim AS Aly MG Thabet ME: Effect of adding nalbuphine to intrathecal bupivacaine with morphine on postoperative nausea and vomiting and pruritus after elective cesarean delivery: A randomized double blinded study. Minerva Anestesiol. 2019;85(3):255–62.

    Not in our library10.23736/s0375-9393.18.12751-9

  248. 248.

    Kaba A Laurent SR Detroz BJ: Intravenous Lidocaine Infusion Facilitates Acute Rehabilitation after Laparoscopic Colectomy. Anesthesiology. 2007;106(1):11–8.

    Not in our library10.1097/00000542-200701000-00007

  249. 249.

    McKay A Gottschalk A Ploppa A: Systemic lidocaine decreased the perioperative opioid analgesic requirements but failed to reduce discharge time after ambulatory surgery. Anesth Analg. 2009;109(6):1805–8.

    Not in our library10.1213/ane.0b013e3181be371b

  250. 250.

    Lauwick S Kim DJ Mistraletti G: Functional walking capacity as an outcome measure of laparoscopic prostatectomy: The effect of lidocaine infusion. Br J Anaesth. 2009;103(2):213–9.

    Not in our library10.1093/bja/aep103

  251. 251.

    Herminghaus A Wachowiak M Wilhelm W: [Intravenous Administration of Lidocaine for Perioperative Analgesia. Review and Recommendations for Practical Usage]. Anaesthesist. 2011;60(2):152–60.

    Not in our library10.1007/s00101-010-1829-0

  252. 252.

    Tikuišis R Miliauskas P Samalavičius NE: Intravenous lidocaine for post-operative pain relief after hand-assisted laparoscopic colon surgery: A randomized, placebo-controlled clinical trial. Tech Coloproctol. 2014;18(4):373–80.

    Not in our library10.1007/s10151-013-1065-0

  253. 253.

    Ahn E Kang H Choi GJ: Intravenous lidocaine for effective pain relief after a laparoscopic colectomy: A prospective, randomized, double-blind, placebo-controlled study. Int Surg. 2015;100(3):394–401.

    Not in our library10.9738/intsurg-d-14-00225.1

  254. 254.

    Weibel S Jokinen J Pace NL: Efficacy and safety of intravenous lidocaine for postoperative analgesia and recovery after surgery: A systematic review with trial sequential analysis. Br J Anaesth. 2016;116(6):770–83.

    Not in our library10.1093/bja/aew101

  255. 255.

    Echevarría GC Altermatt FR Paredes S: Intra-operative lidocaine in the prevention of vomiting after elective tonsillectomy in children: A randomised controlled trial. Eur J Anaesthesiol. 2018;35(5):343–8.

    Not in our library10.1097/eja.0000000000000807

  256. 256.

    Liu ZJ Zhang LY Zheng XG: [Effects of Continuous Intravenous Intraoperative Lidocaine Infusion on Opioids Consumption and Postoperative Recovery in Patients Undergoing Video-assisted Thoracoscopic Lobectomy]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2018;40(2):163–9.

    Not in our library10.3881/j.issn.1000-503x.2018.02.005

  257. 257.

    Wang T Liu H Sun JH: Efficacy of intravenous lidocaine in improving post-operative nausea, vomiting and early recovery after laparoscopic gynaecological surgery. Exp Ther Med. 2019;17(6):4723–4729.

    Not in our library10.3892/etm.2019.7497

  258. 258.

    Dewinter G Moens P Fieuws S: Systemic lidocaine fails to improve postoperative morphine consumption, postoperative recovery and quality of life in patients undergoing posterior spinal arthrodesis. A double-blind, randomized, placebo-controlled trial. Br J Anaesth. 2017;118(4):576–85.

    Not in our library10.1093/bja/aex038

  259. 259.

    Sanchez Munoz MC de Kock M Forget P: What is the place of clonidine in anesthesia? Systematic review and meta-analyses of randomized controlled trials. J Clin Anesth. 2017;38:140–53.

    Not in our library10.1016/j.jclinane.2017.02.003

  260. 260.

    Yang Y Yu LY Zhang WS: Clonidine versus other adjuncts added to local anesthetics for pediatric neuraxial blocks: A systematic review and meta-analysis. J Pain Res. 2018;11:1027–36.

    Not in our library10.2147/jpr.s158264

  261. 261.

    Oddby-Muhrbeck E Eksborg S Bergendahl HTG: Effects of Clonidine on Postoperative Nausea and Vomiting in Breast Cancer Surgery. Anesthesiology. 2002;96(5):1109–14.

    Not in our library10.1097/00000542-200205000-00013

  262. 262.

    Masud M Yeasmeen S Haque AK: Role of Oral Clonidine Premedication on Intra-operative Haemodynamics and PONV in Laparoscopic Cholecystectomy. Mymensingh Med J. 2017;26(4):913–20.

    Not in our library

  263. 263.

    Kobayashi N Ishii S: [Effectiveness of clonidine in postoperative nausea and vomiting--epidural versus oral administration]. Masui. 1997;46(4):538–42.

    Not in our library

  264. 264.

    Segal IS Jarvis DJ Duncan SR: Clinical efficacy of oral-transdermal clonidine combinations during the perioperative period. Anesthesiology. 1991;74(2):220–5.

    Not in our library10.1097/00000542-199102000-00005

  265. 265.

    Allen TK Mishriky BM Klinger RY: The impact of neuraxial clonidine on postoperative analgesia and perioperative adverse effects in women having elective Caesarean section–a systematic review and meta-analysis. Br J Anaesth. 2018;120(2):228–40.

    Not in our library10.1016/j.bja.2017.11.085

  266. 266.

    Shilpa SNG Shailaja S Hilda SS: Comparison of Efficacy of Clonidine versus Ondansetron for Prevention of Nausea and Vomiting Post Thyroidectomy: A Double Blind Randomized Controlled Trial. J Clin Diagn Res. 2015;9(5):UC01–3.

    Not in our library10.7860/jcdr/2015/12721.5866

  267. 267.

    Samieirad S Sharifian-Attar A Eshghpour M: Comparison of Ondansetron versus Clonidine efficacy for prevention of postoperative pain, nausea and vomiting after orthognathic surgeries: A triple blind randomized controlled trial. Med Oral Patol Oral Cir Bucal. 2018;23(6):e767–e776.

    Not in our library10.4317/medoral.22493

  268. 268.

    Carvalho FAE Tenório SB Shiohara FT: Randomized study of postcesarean analgesia with intrathecal morphine alone or combined with clonidine. J Clin Anesth. 2016;33:395–402.

    Not in our library10.1016/j.jclinane.2016.04.024

  269. 269.

    Munsterman C Strauss P: Early Rehydration in Surgical Patients With Prolonged Fasting Decreases Postoperative Nausea and Vomiting. J Perianesth Nurs. 2018;33(5):626–31.

    Not in our library10.1016/j.jopan.2017.06.124

  270. 270.

    Kim HJ Choi SH Eum D: Is perioperative colloid infusion more effective than crystalloid in preventing postoperative nausea and vomiting?: A systematic review and meta-analysis. Medicine (Baltimore). 2019;98(7):e14339.

    Not in our library10.1097/md.0000000000014339

  271. 271.

    Apfel CC Meyer A Orhan-Sungur M: Supplemental intravenous crystalloids for the prevention of postoperative nausea and vomiting: Quantitative review. Br J Anaesth. 2012;108(6):893–902.

    Not in our library10.1093/bja/aes138

  272. 272.

    Jewer JK Wong MJ Bird SJ: Supplemental perioperative intravenous crystalloids for postoperative nausea and vomiting. Cochrane Database Syst Rev. 2019;3(3):CD012212.

    Not in our library10.1002/14651858.cd012212.pub2

  273. 273.

    Ashok V Bala I Bharti N: Effects of intraoperative liberal fluid therapy on postoperative nausea and vomiting in children—A randomized controlled trial. Paediatr Anaesth. 2017;27(8):810–5.

    Not in our library10.1111/pan.13179

  274. 274.

    Chauvin C Schalber-Geyer AS Lefebvre F: Early postoperative oral fluid intake in paediatric day case surgery influences the need for opioids and postoperative vomiting: A controlled randomized trial. Br J Anaesth. 2017;118(3):407–14.

    Not in our library10.1093/bja/aew463

  275. 275.

    Mishra A Pandey RK Sharma A: Is perioperative administration of 5% dextrose effective in reducing the incidence of PONV in laparoscopic cholecystectomy?: A randomized control trial. J Clin Anesth. 2017;40:7–10.

    Not in our library10.1016/j.jclinane.2017.03.048

  276. 276.

    Kim SH Kim DH Kim E: Does perioperative intravenous dextrose reduce postoperative nausea and vomiting? A systematic review and meta-analysis. Ther Clin Risk Manag. 2018;14:2003–11.

    Not in our library10.2147/tcrm.s178952

  277. 277.

    Zorrilla-Vaca A Marmolejo-Posso D Stone A: Perioperative Dextrose Infusion and Postoperative Nausea and Vomiting: A Meta-analysis of Randomized Trials. Anesth Analg. 2019;129(4):943–50.

    Not in our library10.1213/ane.0000000000004019

  278. 278.

    Shibata C Sasaki I Naito H: The herbal medicine Dai-Kenchu-Tou stimulates upper gut motility through cholinergic and 5-hydroxytryptamine 3 receptors in conscious dogs. Surgery. 1999;126(5):918–24.

    Not in our library10.1016/s0039-6060(99)70033-4

  279. 279.

    Abdel-Aziz H Windeck T Ploch M: Mode of action of gingerols and shogaols on 5-HT 3 receptors: Binding studies, cation uptake by the receptor channel and contraction of isolated guinea-pig ileum. Eur J Pharmacol. 2006;530(1–2):136–43.

    Not in our library10.1016/j.ejphar.2005.10.049

  280. 280.

    Hu ML Rayner CK Wu KL: Effect of ginger on gastric motility and symptoms of functional dyspepsia. World J Gastroenterol. 2011;17(1):105–10.

    Not in our library10.3748/wjg.v17.i1.105

  281. 281.

    Fahimi F Khodadad K Amini S: Evaluating the effect of zingiber officinalis on nausea and vomiting in patients receiving Cisplatin based regimens. Iran J Pharm Res. 2011;10(2):379–84.

    Not in our library

  282. 282.

    Adib-Hajbaghery M Hosseini FS: Investigating the effects of inhaling ginger essence on post-nephrectomy nausea and vomiting. Complement Ther Med. 2015;23(6):827–31.

    Not in our library10.1016/j.ctim.2015.10.002

  283. 283.

    Ozgoli G Goli M Simbar M: Effects of ginger capsules on pregnancy, nausea, and vomiting. J Altern Complement Med. 2009;15(3):243–6.

    Not in our library10.1089/acm.2008.0406

  284. 284.

    Hall HG Griffiths DL McKenna LG: The use of complementary and alternative medicine by pregnant women: A literature review. Midwifery. 2011;27(6):817–24.

    Not in our library10.1016/j.midw.2010.08.007

  285. 285.

    Shawahna R Taha A: Which potential harms and benefits of using ginger in the management of nausea and vomiting of pregnancy should be addressed? a consensual study among pregnant women and gynecologists. BMC Complement Altern Med. 2017;17(1):204.

    Not in our library10.1186/s12906-017-1717-0

  286. 286.

    Marx W McCarthy AL Ried K: The Effect of a Standardized Ginger Extract on Chemotherapy-Induced Nausea-Related Quality of Life in Patients Undergoing Moderately or Highly Emetogenic Chemotherapy: A Double Blind, Randomized, Placebo Controlled Trial. Nutrients. 2017;9(8):867.

    Not in our library10.3390/nu9080867

  287. 287.

    Albooghobeish M Ghomeishi A Adarvishi S: The Effect of Preoperative Zintoma Capsule on Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy. Anesth Pain Med. 2018;8(5):e67132.

    Not in our library10.5812/aapm.67132

  288. 288.

    Soltani E Jangjoo A Aghaei MA: Effects of preoperative administration of ginger (Zingiber officinale Roscoe) on postoperative nausea and vomiting after laparoscopic cholecystectomy. J Tradit Complement Med. 2018;8(3):387–90.

    Not in our library10.1016/j.jtcme.2017.06.008

  289. 289.

    Bameshki A Namaiee MH Jangjoo A: Effect of oral ginger on prevention of nausea and vomiting after laparoscopic cholecystectomy: A double-blind, randomized, placebo-controlled trial. Electron Physician. 2018;10(2):6354–62.

    Not in our library10.19082/6354

  290. 290.

    Tóth B Lantos T Hegyi P: Ginger ( Zingiber officinale): An alternative for the prevention of postoperative nausea and vomiting. A meta-analysis. Phytomedicine. 2018;50:8–18.

    Not in our library10.1016/j.phymed.2018.09.007

  291. 291.

    Hosseini FS Adib-Hajbaghery M: Ginger Essence Effect on Nausea and Vomiting After Open and Laparoscopic Nephrectomies. Nurs Midwifery Stud. 2015;4(2):e28625.

    Not in our library10.17795/nmsjournal28625

  292. 292.

    Mandal P Das A Majumdar S: The efficacy of ginger added to ondansetron for preventing postoperative nausea and vomiting in ambulatory surgery. Pharmacognosy Res. 2014;6(1):52–7.

    Not in our library10.4103/0974-8490.122918

  293. 293.

    Nanthakomon T Pongrojpaw D: The efficacy of ginger in prevention of postoperative nausea and vomiting after major gynecologic surgery. J Med Assoc Thai. 2006;89 Suppl 4:S130–6.

    Not in our library

  294. 294.

    Kalava A Darji SJ Kalstein A: Efficacy of ginger on intraoperative and postoperative nausea and vomiting in elective cesarean section patients. Eur J Obstet Gynecol Reprod Biol. 2013;169(2):184–8.

    Not in our library10.1016/j.ejogrb.2013.02.014

  295. 295.

    Zeraati H Shahinfar J Hesari SI: The Effect of Ginger Extract on the Incidence and Severity of Nausea and Vomiting After Cesarean Section Under Spinal Anesthesia. Anesth Pain Med. 2016;6(5):e38943.

    Not in our library10.5812/aapm.38943

  296. 296.

    Lee YR Shin HS: Effectiveness of Ginger Essential Oil on Postoperative Nausea and Vomiting in Abdominal Surgery Patients. J Altern Complement Med. 2017;23(3):196–200.

    Not in our library10.1089/acm.2015.0328

  297. 297.

    Chaiyakunapruk N Kitikannakorn N Nathisuwan S: The efficacy of ginger for the prevention of postoperative nausea and vomiting: A meta-analysis. Am J Obstet Gynecol. 2006;194(1):95–9.

    Not in our library10.1016/j.ajog.2005.06.046

  298. 298.

    Seidi J Ebnerasooli S Shahsawari S: The Influence of Oral Ginger before Operation on Nausea and Vomiting after Cataract Surgery under General Anesthesia: A double-blind placebo-controlled randomized clinical trial. Electron Physician. 2017;9(1):3508–14.

    Not in our library10.19082/3508

  299. 299.

    Tavlan A Tuncer S Erol A: Prevention of postoperative nausea and vomiting after thyroidectomy: Combined antiemetic treatment with dexamethasone and ginger versus dexamethasone alone. Clin Drug Investig. 2006;26(4):209–14.

    Not in our library10.2165/00044011-200626040-00005

  300. 300.

    Morin AM Betz O Kranke P: [Is Ginger a Relevant Antiemetic for Postoperative Nausea and Vomiting?]. Anasthesiol Intensivmed Notfallmed Schmerzther. 2004;39(5):281–5.

    Not in our library10.1055/s-2004-814438

  301. 301.

    Arfeen Z Owen H Plummer JL: A Double-Blind Randomized Controlled Trial of Ginger for the Prevention of Postoperative Nausea and Vomiting. Anaesth Intensive Care. 2019;23(4):449–52.

    Not in our library10.1177/0310057x9502300406

  302. 302.

    Eberhart LHJ Mayer R Betz O: Ginger does not prevent postoperative nausea and vomiting after laparoscopic surgery. Anesth Analg. 2003;96(4):995–8,table of contents.

    Not in our library10.1213/01.ane.0000055818.64084.41

  303. 303.

    Wang SM Hofstadter MB Kain ZN: An alternative method to alleviate postoperative nausea and vomiting in children. J Clin Anesth. 1999;11(3):231–4.

    Not in our library10.1016/s0952-8180(99)00035-5

  304. 304.

    Merritt BA Okyere CP Jasinski DM: Isopropyl alcohol inhalation: Alternative treatment of postoperative nausea and vomiting. Nurs Res. 2002;51(2):125–8.

    Not in our library10.1097/00006199-200203000-00009

  305. 305.

    Anderson LA Gross JB: Aromatherapy with peppermint, isopropyl alcohol, or placebo is equally effective in relieving postoperative nausea. J Perianesth Nurs. 2004;19(1):29–35.

    Not in our library10.1016/j.jopan.2003.11.001

  306. 306.

    Beadle KL Helbling AR Love SL: Isopropyl Alcohol Nasal Inhalation for Nausea in the Emergency Department: A Randomized Controlled Trial. Ann Emerg Med. 2016;68(1):1–9.e1.

    Not in our library10.1016/j.annemergmed.2015.09.031

  307. 307.

    Verma DK Bansal S Sharma P: Control of Postoperative Nausea and Vomiting in Oral and Maxillofacial Surgery Patients with Isopropyl Alcohol: A Prospective Randomized Clinical Trial. J Maxillofac Oral Surg. 2018;17(4):576–81.

    Not in our library10.1007/s12663-018-1094-3

  308. 308.

    Asay K Olson C Donnelly J: The Use of Aromatherapy in Postoperative Nausea and Vomiting: A Systematic Review. J Perianesth Nurs. 2019;34(3):502–16.

    Not in our library10.1016/j.jopan.2018.08.006

  309. 309.

    Mcilvoy L Richmer L Kramer D: The Efficacy of Aromatherapy in the Treatment of Postdischarge Nausea in Patients Undergoing Outpatient Abdominal Surgery. J Perianesth Nurs. 2015;30(5):383–8.

    Not in our library10.1016/j.jopan.2014.10.004

  310. 310.

    Karaman S Karaman T Tapar H: A randomized placebo-controlled study of aromatherapy for the treatment of postoperative nausea and vomiting. Complement Ther Med. 2019;42:417–21.

    Not in our library10.1016/j.ctim.2018.12.019

  311. 311.

    Brown L Danda L Fahey TJ: A Quality Improvement Project to Determine the Effect of Aromatherapy on Postoperative Nausea and Vomiting in a Short-Stay Surgical Population. AORN J. 2018;108(4):361–9.

    Not in our library10.1002/aorn.12366

  312. 312.

    Stallings-Welden LM Doerner M Ketchem E: A Comparison of Aromatherapy to Standard Care for Relief of PONV and PDNV in Ambulatory Surgical Patients. J Perianesth Nurs. 2018;33(2):116–28.

    Not in our library10.1016/j.jopan.2016.09.001

  313. 313.

    Hodge NS McCarthy MS Pierce RM: A prospective randomized study of the effectiveness of aromatherapy for relief of postoperative nausea and vomiting. J Perianesth Nurs. 2014;29(1):5–11.

    Not in our library10.1016/j.jopan.2012.12.004

  314. 314.

    Hines S Steels E Chang A: Aromatherapy for treatment of postoperative nausea and vomiting. Cochrane Database Syst Rev. 2018;3(3):CD007598.

    Not in our library10.1002/14651858.cd007598.pub3

  315. 315.

    Hines S Steels E Chang A: Aromatherapy for treatment of postoperative nausea and vomiting. Cochrane Database Syst Rev. 2012; (4):CD007598.

    Not in our library10.1002/14651858.cd007598.pub2

  316. 316.

    Lane B Cannella K Bowen C: Examination of the Effectiveness of Peppermint Aromatherapy on Nausea in Women Post C-Section. J Holist Nurs. 2012;30(2):90–104.

    Not in our library10.1177/0898010111423419

  317. 317.

    Ferruggiari L Ragione B Rich ER: The effect of aromatherapy on postoperative nausea in women undergoing surgical procedures. J Perianesth Nurs. 2012;27(4):246–51.

    Not in our library10.1016/j.jopan.2012.01.013

  318. 318.

    Kiberd MB Clarke SK Chorney J: Aromatherapy for the treatment of PONV in children: A pilot RCT. BMC Complement Altern Med. 2016;16(1):450.

    Not in our library10.1186/s12906-016-1441-1

  319. 319.

    Fan CF Tanhui E Joshi S: Acupressure treatment for prevention of postoperative nausea and vomiting. Anesth Analg. 1997;84(4):821–5.

    Not in our library10.1097/00000539-199704000-00023

  320. 320.

    Alkaissi A Evertsson K Johnsson VA: P6 acupressure may relieve nausea and vomiting after gynecological surgery: An effectiveness study in 410 women. Can J Anaesth. 2002;49(10):1034–9.

    Not in our library10.1007/bf03017897

  321. 321.

    Rusy LM Hoffman GM Weisman SJ: Electroacupuncture prophylaxis of postoperative nausea and vomiting following pediatric tonsillectomy with or without adenoidectomy. Anesthesiology. 2002;96(2):300–5.

    Not in our library10.1097/00000542-200202000-00013

  322. 322.

    Albooghobeish M Mohtadi A Saidkhani V: Comparison Between Effects of Acupuncture and Metoclopramide on Postoperative Nausea and Vomiting after Gynaecological Laparoscopy: A Randomized Controlled Trial. Anesth Pain Med. 2017;7(5):e12876.

    Not in our library10.5812/aapm.12876

  323. 323.

    Constantine FC Matarasso A: Putting It All Together: Recommendations for Improving Pain Management in Body Contouring. Plast Reconstr Surg. 2014;134(4 Suppl 2):113S–119S.

    Not in our library10.1097/prs.0000000000000669

  324. 324.

    Larson JD Gutowski KA Marcus BC: The effect of electroacustimulation on postoperative nausea, vomiting, and pain in outpatient plastic surgery patients: A prospective, randomized, blinded, clinical trial. Plast Reconstr Surg. 2010;125(3):989–94.

    Not in our library10.1097/prs.0b013e3181ccdc23

  325. 325.

    Lee A Done ML: The use of nonpharmacologic techniques to prevent postoperative nausea and vomiting: A meta-analysis. Anesth Analg. 1999;88(6):1362–9.

    Not in our library10.1097/00000539-199906000-00031

  326. 326.

    Lu C Du JY Fang JQ: [The curative effect observation of different frequency of TEAS combined with wristband pressing on Neiguan (PC 6) for nausea and vomiting after laparoscopic cholecystectomy]. Zhongguo Zhen Jiu. 2019;39(1):9–15.

    Not in our library10.13703/j.0255-2930.2019.01.002

  327. 327.

    Gan TJ Jiao KR Zenn M: A randomized controlled comparison of electro-acupoint stimulation or ondansetron versus placebo for the prevention of postoperative nausea and vomiting. Anesth Analg. 2004;99(4):1070–5, table of contents.

    Not in our library10.1213/01.ane.0000130355.91214.9e

  328. 328.

    Lee A Fan LT: Stimulation of the wrist acupuncture point P6 for preventing postoperative nausea and vomiting. Cochrane Database Syst Rev. 2009; (2):CD003281.

    Not in our library10.1002/14651858.cd003281.pub3

  329. 329.

    Gouveia F Oliveira C Losa N: Acupuncture in the Management of Intraoperative Nausea and Vomiting. J Acupunct Meridian Stud. 2016;9(6):325–9.

    Not in our library10.1016/j.jams.2016.09.005

  330. 330.

    Moore CB Hickey AH: Increasing Access to Auricular Acupuncture for Postoperative Nausea and Vomiting. J Perianesth Nurs. 2017;32(2):96–105.

    Not in our library10.1016/j.jopan.2015.06.006

  331. 331.

    Carr KL Johnson FE Kenaan CA: Effects of P6 stimulation on postoperative nausea and vomiting in laparoscopic cholecystectomy patients. J Perianesth Nurs. 2015;30(2):143–50.

    Not in our library10.1016/j.jopan.2014.04.005

  332. 332.

    Farhadi K Choubsaz M Setayeshi K: The Effectiveness of Dry-Cupping in Preventing Post-Operative Nausea and Vomiting by P6 Acupoint Stimulation: A Randomized Controlled Trial. Medicine (Baltimore). 2016;95(38):e4770.

    Not in our library10.1097/md.0000000000004770

  333. 333.

    Lee S Lee MS Choi DH: Electroacupuncture on PC6 prevents opioid-induced nausea and vomiting after laparoscopic surgery. Chin J Integr Med. 2013;19(4):277–81.

    Not in our library10.1007/s11655-013-1425-7

  334. 334.

    Ünülü M Kaya N: The Effect of Neiguan Point (P6) Acupressure With Wristband on Postoperative Nausea, Vomiting, and Comfort Level: A Randomized Controlled Study. J Perianesth Nurs. 2018;33(6):915–27.

    Not in our library10.1016/j.jopan.2017.09.006

  335. 335.

    Stott A: Examining the efficacy of stimulating the PC6 wrist acupuncture point for preventing postoperative nausea and vomiting: A Cochrane review summary. Int J Nurs Stud. 2016;64:139–41.

    Not in our library10.1016/j.ijnurstu.2016.07.004

  336. 336.

    Stoicea N Gan TJ Joseph N: Alternative Therapies for the Prevention of Postoperative Nausea and Vomiting. Front Med (Lausanne). 2015;2:87.

    Not in our library10.3389/fmed.2015.00087

  337. 337.

    Kwon JH Shin Y Juon HS: Effects of Nei-Guan (P6) Acupressure Wristband: On Nausea, Vomiting, and Retching in Women After Thyroidectomy. Cancer Nurs. 2016;39(1):61–6.

    Not in our library10.1097/ncc.0000000000000243

  338. 338.

    Sun R Dai W Liu Y: Non-needle acupoint stimulation for prevention of nausea and vomiting after breast surgery: A meta-analysis. Medicine (Baltimore). 2019;98(10):e14713.

    Not in our library10.1097/md.0000000000014713

  339. 339.

    Li S Zheng M Wu W: Effects of Electroacupuncture Administered 24 hours Prior to Surgery on Postoperative Nausea and Vomiting and Pain in Patients Undergoing Gynecologic Laparoscopic Surgery: A Feasibility Study. Explore (NY). 2017;13(5):313–8.

    Not in our library10.1016/j.explore.2017.06.002

  340. 340.

    Hofmann D Murray C Beck J: Acupressure in Management of Postoperative Nausea and Vomiting in High-Risk Ambulatory Surgical Patients. J Perianesth Nurs. 2017;32(4):271–8.

    Not in our library10.1016/j.jopan.2015.09.010

  341. 341.

    Oh H Kim BH: Comparing Effects of Two Different Types of Nei-Guan Acupuncture Stimulation Devices in Reducing Postoperative Nausea and Vomiting. J Perianesth Nurs. 2017;32(3):177–87.

    Not in our library10.1016/j.jopan.2015.12.010

  342. 342.

    Feng C Popovic J Kline R: Auricular Acupressure in the Prevention of Postoperative Nausea and Emesis A Randomized Controlled Trial. Bull Hosp Jt Dis (2013). 2017;75(2):114–8.

    Not in our library

  343. 343.

    Weeks EM Trinca J Zheng Z: Knowledge of and willingness to try acupuncture for postoperative nausea and vomiting: An Australian survey of surgical patients. Acupunct Med. 2017;35(5):345–51.

    Not in our library10.1136/acupmed-2016-011191

  344. 344.

    Liu Y Wang M Li Q: [Impacts of transcutaneous acupoint electric stimulation on the postoperative nausea and vomiting and plasma 5-HT concentration after cesarean section]. Zhongguo Zhen Jiu. 2015;35(10):1039–43.

    Not in our library

  345. 345.

    Lin M Xiong X Wei W: Effect of auricular point therapy combined with transcutaneous electrical acupoint stimulation on prevention of postoperative nausea and vomiting in patients undergoing partial breast resection. J Pract Med. 2015;31:1858–60.

    Not in our library

  346. 346.

    Pan F Gong H He B: Preventive and therapeutic effects of different acupoints and stimulating methods on nausea and vomiting after breast surgery. J New Chin Med. 2014;46:169–71.

    Not in our library

  347. 347.

    Wang Z Zeng F Qian B: Effects of transcutaneous electrical acupoint stimulation on postoperative recovery quality after breast cancer surgery. Med J West China. 2017;29:1233–6.

    Not in our library

  348. 348.

    Zhou W Hu L Ye J: Effect of percutaneous acupoint electrical stimulation on adverse reactions after modified radical mastectomy for breast cancer. Chin J Rural Med Pharm. 2017;24:27–8.

    Not in our library

  349. 349.

    Quinlan-Woodward J Gode A Dusek JA: Assessing the Impact of Acupuncture on Pain, Nausea, Anxiety, and Coping in Women Undergoing a Mastectomy. Oncol Nurs Forum. 2016;43(6):725–32.

    Not in our library10.1188/16.onf.725-732

  350. 350.

    Pouy S Etebarian A Azizi-Qadikolaee A: The effect of acupuncture on postoperative pain, nausea and vomiting after pediatric tonsillectomy: A systematic review. Int J Adolesc Med Health. 2019.

    Not in our library10.1515/ijamh-2018-0285

  351. 351.

    Shin HC Kim JS Lee SK: The effect of acupuncture on postoperative nausea and vomiting after pediatric tonsillectomy: A meta-analysis and systematic review. Laryngoscope. 2016;126(8):1761–7.

    Not in our library10.1002/lary.25883

  352. 352.

    Özmert S Salman N Sever F: Acupuncture as an Antiemetic in Children who Underwent Adenoidectomy and/or Tonsillectomy. Turk J Anaesthesiol Reanim. 2016;44(1):7–12.

    Not in our library10.5152/tjar.2016.05902

  353. 353.

    Liodden I Howley M Grimsgaard AS: Perioperative Acupuncture and Postoperative Acupressure Can Prevent Postoperative Vomiting following Paediatric Tonsillectomy Or Adenoidectomy: A Pragmatic Randomised Controlled Trial. Acupunct Med. 2018;29(1):9–15.

    Not in our library10.1136/aim.2010.002915

  354. 354.

    Shin BC: Acupuncture for post- tonsillectomy pain: evidence from a recent randomized clinical trial. Longhua Chinese Medicine. 2018; Icm.amegroups.com.

    Not in our library10.21037/lcm.2018.09.02

  355. 355.

    Ochi JW Richardson AC: Intraoperative pediatric acupuncture is widely accepted by parents. Int J Pediatr Otorhinolaryngol. 2018;110:12–5.

    Not in our library10.1016/j.ijporl.2018.04.014

  356. 356.

    Ghezelbash S Khosravi M: Acupressure for nausea-vomiting and fatigue management in acute lymphoblastic leukemia children. J Nurs Midwifery Sci. 2017;4(3):75–81.

    Not in our library10.4103/jnms.jnms_11_17

  357. 357.

    Goel H Mathur S Sandhu M: Effect of Low-level LASER Therapy on P6 Acupoint to Control Gag Reflex in Children: A Clinical Trial. J Acupunct Meridian Stud. 2017;10(5):317–23.

    Not in our library10.1016/j.jams.2017.07.002

  358. 358.

    Butkovic D Toljan S Matolic M: Comparison of laser acupuncture and metoclopramide in PONV prevention in children. Paediatr Anaesth. 2005;15(1):37–40.

    Not in our library10.1111/j.1460-9592.2004.01388.x

  359. 359.

    Barsoum G Perry EP Fraser IA: Postoperative nausea is relieved by acupressure. J R Soc Med. 1990;83(2):86–9.

    Not in our library10.1177/014107689008300209

  360. 360.

    Varejão CdS Santo FHdE: Laser Acupuncture for Relieving Nausea and Vomiting in Pediatric Patients Undergoing Chemotherapy: A Single-Blind Randomized Clinical Trial. J Pediatr Oncol Nurs. 2018;36(1):44–54.

    Not in our library10.1177/1043454218810140

  361. 361.

    Martin CS Deverman SE Norvell DC: Randomized trial of acupuncture with antiemetics for reducing postoperative nausea in children. Acta Anaesthesiol Scand. 2019;63(3):292–7.

    Not in our library10.1111/aas.13288

  362. 362.

    Hasheminasab FS Ayati MH: A review on the efficacy of acupuncture to prevent nausea and vomiting after strabismus surgery. Trad Integr Med. 2017;2(2):90–7. Reference Source

    Not in our library

  363. 363.

    Yilmaz Sahin S Iyigun E Can MF: Effect of acupressure application to the P6 acupoint before laparoscopic cholecystectomy on postoperative nausea-vomiting: A randomized controlled clinical study. Int J Nurs Stud. 2018;87:40–8.

    Not in our library10.1016/j.ijnurstu.2018.07.011

  364. 364.

    Liu WH Hao Y Han YJ: Analysis and Thoughts about the Negative Results of International Clinical Trials on Acupuncture. Evid Based Complement Alternat Med. 2015;2015:671242.

    Not in our library10.1155/2015/671242

  365. 365.

    Christensen KA Gosse BJ Hildebrand C: Acupuncture-Associated Vasovagal Response: Revised Terminology and Hospital Experience. Med Acupunct. 2017;29(6):366–76.

    Not in our library10.1089/acu.2017.1245

  366. 366.

    Gilbert RT Farish N Bergland E: The Use of Short-Term Acupressure to Prevent Long-Term PONV: Was This a Case of Too Little, Too Late? J Perianesth Nurs. 2017;32(5):445–52.

    Not in our library10.1016/j.jopan.2015.08.014

  367. 367.

    Jernigan AM Chen CCG Sewell C: A randomized trial of chewing gum to prevent postoperative ileus after laparotomy for benign gynecologic surgery. Int J Gynaecol Obstet. 2014;127(3):279–82.

    Not in our library10.1016/j.ijgo.2014.06.008

  368. 368.

    Darvall JN Handscombe M Leslie K: Chewing gum for the treatment of postoperative nausea and vomiting: A pilot randomized controlled trial. Br J Anaesth. 2017;118(1):83–9.

    Not in our library10.1093/bja/aew375

  369. 369.

    Ciardulli A Saccone G Di Mascio D: Chewing gum improves postoperative recovery of gastrointestinal function after cesarean delivery: A systematic review and meta-analysis of randomized trials. J Matern Fetal Neonatal Med. 2018;31(14):1924–32.

    Not in our library10.1080/14767058.2017.1330883

  370. 370.

    Xu C Peng J Liu S: Effect of chewing gum on gastrointestinal function after gynecological surgery: A systematic literature review and meta-analysis. J Obstet Gynaecol Res. 2018;44(5):936–43.

    Not in our library10.1111/jog.13602

  371. 371.

    Ge B Zhao H Lin R: Influence of gum-chewing on postoperative bowel activity after laparoscopic surgery for gastric cancer: A randomized controlled trial. Medicine (Baltimore). 2017;96(13):e6501.

    Not in our library10.1097/md.0000000000006501

  372. 372.

    Mason KP: Pediatric Sedation Outside of the Operating Room: A Multispecialty International Collaboration. New York: Springer.2015

    Not in our library10.1007/978-1-4939-1390-9

  373. 373.

    Hole J Hirsch M Ball E: Music as an aid for postoperative recovery in adults: A systematic review and meta-analysis. Lancet. 2015;386(10004):1659–71.

    Not in our library10.1016/s0140-6736(15)60169-6

  374. 374.

    Flanagan DA Kerin A: How is intraoperative music therapy beneficial to adult patients undergoing general anesthesia? A systematic review. Anesthesia eJ. 2017;5(2):5–13. Reference Source

    Not in our library

  375. 375.

    Nilsson U Rawal N Uneståhl LE: Improved recovery after music and therapeutic suggestions during general anaesthesia: A double-blind randomised controlled trial. Acta Anaesthesiol Scand. 2001;45(7):812–7.

    Not in our library10.1034/j.1399-6576.2001.045007812.x

  376. 376.

    Allred KD Byers JF Sole ML: The effect of music on postoperative pain and anxiety. Pain Manag Nurs. 2010;11(1):15–25.

    Not in our library10.1016/j.pmn.2008.12.002

  377. 377.

    Kahloul M Mhamdi S Nakhli MS: Effects of music therapy under general anesthesia in patients undergoing abdominal surgery. Libyan J Med. 2017;12(1):1260886.

    Not in our library10.1080/19932820.2017.1260886

  378. 378.

    Palmer JB Lane D Mayo D: Effects of Music Therapy on Anesthesia Requirements and Anxiety in Women Undergoing Ambulatory Breast Surgery for Cancer Diagnosis and Treatment: A Randomized Controlled Trial. J Clin Oncol. 2015;33(28):3162–8.

    Not in our library10.1200/jco.2014.59.6049

  379. 379.

    Bradt J Dileo C Shim M: Music interventions for preoperative anxiety. Cochrane Database Syst Rev. 2013; (6):CD006908.

    Not in our library10.1002/14651858.cd006908.pub2

  380. 380.

    van der Heijden MJE Oliai Araghi S van Dijk M: The Effects of Perioperative Music Interventions in Pediatric Surgery: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. PLoS One. 2015;10(8):e0133608.

    Not in our library10.1371/journal.pone.0133608

  381. 381.

    Sin WM Chow KM: Effect of Music Therapy on Postoperative Pain Management in Gynecological Patients: A Literature Review. Pain Manag Nurs. 2015;16(6):978–87.

    Not in our library10.1016/j.pmn.2015.06.008

  382. 382.

    Manyande A Cyna AM Yip P: Non-pharmacological interventions for assisting the induction of anaesthesia in children. Cochrane Database Syst Rev. 2015; (7):CD006447.

    Not in our library10.1002/14651858.cd006447.pub3

  383. 383.

    Good M Anderson GC Ahn S: Relaxation and music reduce pain following intestinal surgery. Res Nurs Health. 2005;28(3):240–51.

    Not in our library10.1002/nur.20076

  384. 384.

    Good M Anderson GC Stanton-Hicks M: Relaxation and music reduce pain after gynecologic surgery. Pain Management Nursing. 2002;3(2):61–70.

    Not in our library10.1053/jpmn.2002.123846

  385. 385.

    Binns-Turner PG Wilson LL Pryor ER: Perioperative music and its effects on anxiety, hemodynamics, and pain in women undergoing mastectomy. AANA J. 2011;79(4 Suppl):S21–7.

    Not in our library

  386. 386.

    Bringman H Giesecke K Thörne A: Relaxing music as pre-medication before surgery: A randomised controlled trial. Acta Anaesthesiol Scand. 2009;53(6):759–64.

    Not in our library10.1111/j.1399-6576.2009.01969.x

  387. 387.

    Madson AT Silverman MJ: The Effect of Music Therapy on Relaxation, Anxiety, Pain Perception, and Nausea in Adult Solid Organ Transplant Patients. J Music Ther. 2010;47(3):220–32.

    Not in our library10.1093/jmt/47.3.220

  388. 388.

    Jayaraman L Sharma S Sethi N: Does intraoperative music therapy or positive therapeutic suggestions during general anaesthesia affect the postoperative outcome? - A double blind randomised controlled. Indian J. Anaesth. 2006;50(4):258–61. Reference Source

    Not in our library

  389. 389.

    Çetinkaya F: The effects of listening to music on the postoperative nausea and vomiting. Complement Ther Clin Pract. 2019;35:278–83.

    Not in our library10.1016/j.ctcp.2019.03.003

  390. 390.

    Gokçek E Kaydu A: The effects of music therapy in patients undergoing septorhinoplasty surgery under general anesthesia. Braz J Otorhinolaryngol. 2019; S1808-8694(18)30606-2.

    Not in our library10.1016/j.bjorl.2019.01.008

  391. 391.

    Kurdi MS Gasti V: Intraoperative Meditation Music as an Adjunct to Subarachnoid Block for the Improvement of Postoperative Outcomes Following Cesarean Section: A Randomized Placebo-controlled Comparative Study. Anesth Essays Res. 2018;12(3):618–24.

    Not in our library10.4103/aer.aer_114_18

  392. 392.

    Çankaya A Saritaş S: Effect of Classic Foot Massage on Vital Signs, Pain, and Nausea/Vomiting Symptoms After Laparoscopic Cholecystectomy. Surg Laparosc Endosc Percutan Tech. 2018;28(6):359–65.

    Not in our library10.1097/sle.0000000000000586

  393. 393.

    Johns DE Gerling V Pasker-de Jong PCM: Ice pops in the recovery room: Effects on postoperative nausea and vomiting. Br J Anaesth. 2017;118(4):637–8.

    Not in our library10.1093/bja/aex063

  394. 394.

    Li G Lin L Dai F: Muscular tissue oxygen saturation during robotic hysterectomy and postoperative nausea and vomiting: Exploring the potential therapeutic thresholds. J Clin Monit Comput. 2019;33(4):597–604.

    Not in our library10.1007/s10877-018-0193-5

  395. 395.

    Guo W Ding J Jin X: Effect of cerebral oxygen saturation on postoperative nausea and vomiting in female laparoscopic surgery patients. Medicine (Baltimore). 2017;96(41):e8275.

    Not in our library10.1097/md.0000000000008275

  396. 396.

    Alghanem SM Massad IM Rashed EM: Optimization of anesthesia antiemetic measures versus combination therapy using dexamethasone or ondansetron for the prevention of postoperative nausea and vomiting. Surg Endosc. 2010;24(2):353–8.

    Not in our library10.1007/s00464-009-0567-3

  397. 397.

    Tang J Chen X White PF: Antiemetic prophylaxis for office-based surgery: Are the 5-HT3 receptor antagonists beneficial? Anesthesiology. 2003;98(2):293–8.

    Not in our library10.1097/00000542-200302000-00005

  398. 398.

    Eberhart LHJ Mauch M Morin AM: Impact of a multimodal anti-emetic prophylaxis on patient satisfaction in high-risk patients for postoperative nausea and vomiting. Anaesthesia. 2002;57(10):1022–7.

    Not in our library10.1046/j.1365-2044.2002.02822.x

  399. 399.

    Pym A Ben-Menachem E: The effect of a multifaceted postoperative nausea and vomiting reduction strategy on prophylaxis administration amongst higher-risk adult surgical patients. Anaesth Intensive Care. 2018;46(2):185–9.

    Not in our library10.1177/0310057x1804600207

  400. 400.

    Tabrizi S Malhotra V Turnbull ZA: Implementation of Postoperative Nausea and Vomiting Guidelines for Female Adult Patients Undergoing Anesthesia During Gynecologic and Breast Surgery in an Ambulatory Setting. J Perianesth Nurs. 2019;34(4):851–60.

    Not in our library10.1016/j.jopan.2018.10.006

  401. 401.

    Walldén J Flodin J Hultin M: Validation of a prediction model for post-discharge nausea and vomiting after general anaesthesia in a cohort of Swedish ambulatory surgery patients. Eur J Anaesthesiol. 2016;33(10):743–9.

    Not in our library10.1097/eja.0000000000000473

  402. 402.

    King AB Spann MD Jablonski P: An enhanced recovery program for bariatric surgical patients significantly reduces perioperative opioid consumption and postoperative nausea. Surg Obes Relat Dis. 2018;14(6):849–56.

    Not in our library10.1016/j.soard.2018.02.010

  403. 403.

    Scuderi PE James RL Harris L: Multimodal Antiemetic Management Prevents Early Postoperative Vomiting After Outpatient Laparoscopy. Anesth Analg. 2000;91(6):1408–14.

    Not in our library10.1097/00000539-200012000-00020

  404. 404.

    Bruderer U Fisler A Steurer MP: Post-discharge nausea and vomiting after total intravenous anaesthesia and standardised PONV prophylaxis for ambulatory surgery. Acta Anaesthesiol Scand. 2017;61(7):758–66.

    Not in our library10.1111/aas.12921

  405. 405.

    Bergese SD Antor MA Uribe AA: Triple Therapy with Scopolamine, Ondansetron, and Dexamethasone for Prevention of Postoperative Nausea and Vomiting in Moderate to High-Risk Patients Undergoing Craniotomy Under General Anesthesia: A Pilot Study. Front Med (Lausanne). 2015;2:40.

    Not in our library10.3389/fmed.2015.00040

  406. 406.

    Henzi I Walder B Tramèr MR: Dexamethasone for the Prevention of Postoperative Nausea and Vomiting: A Quantitative Systematic Review. Anesth Analg. 2000;90(1):186–94.

    Not in our library10.1097/00000539-200001000-00038

  407. 407.

    Singh LD Singh YN Singh NR: A comparative study between ramosetron and granisetron for the prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy. J Med Soc. 2013;27(3):194–198.

    Not in our library10.4103/0972-4958.127392

  408. 408.

    Chu CC Shieh JP Tzeng JI: The prophylactic effect of haloperidol plus dexamethasone on postoperative nausea and vomiting in patients undergoing laparoscopically assisted vaginal hysterectomy. Anesth Analg. 2008;106(5):1402–6.

    Not in our library10.1213/ane.0b013e3181609424

  409. 409.

    Habib AS El-Moalem HE Gan TJ: The efficacy of the 5-HT3 receptor antagonists combined with droperidol for PONV prophylaxis is similar to their combination with dexamethasone. A meta-analysis of randomized controlled trials. Can J Anesth. 2004;51(4):311–9.

    Not in our library10.1007/bf03018234

  410. 410.

    Maddali MM Mathew J Fahr J: Postoperative nausea and vomiting in diagnostic gynaecological laparoscopic procedures: Comparison of the efficacy of the combination of dexamethasone and metoclopramide with that of dexamethasone and ondansetron. J Postgrad Med. 2003;49(4):302–6.

    Not in our library

  411. 411.

    Gan TJ Franiak R Reeves J: Ondansetron orally disintegrating tablet versus placebo for the prevention of postdischarge nausea and vomiting after ambulatory surgery. Anesth Analg. 2002;94(5):1199–200.

    Not in our library10.1097/00000539-200205000-00027

  412. 412.

    Dewinter G Staelens W Veef E: Simplified algorithm for the prevention of postoperative nausea and vomiting: A before-and-after study. Br J Anaesth. 2018;120(1):156–63.

    Not in our library10.1016/j.bja.2017.08.003

  413. 413.

    Kumar A Solanki SL Gangakhedkar GR: Comparison of palonosetron and dexamethasone with ondansetron and dexamethasone for postoperative nausea and vomiting in postchemotherapy ovarian cancer surgeries requiring opioid-based patient-controlled analgesia: A randomised, double-blind, active controlled study. Indian J Anaesth. 2018;62(10):773–9.

    Not in our library10.4103/ija.ija_437_18

  414. 414.

    Ryu JH Jeon YT Min B: Effects of palonosetron for prophylaxis of postoperative nausea and vomiting in high-risk patients undergoing total knee arthroplasty: A prospective, randomized, double-blind, placebo-controlled study. PLoS One. 2018;13(5):e0196388.

    Not in our library10.1371/journal.pone.0196388

  415. 415.

    Tramèr MR: A rational approach to the control of postoperative nausea and vomiting: Evidence from systematic reviews. Part I. Efficacy and harm of antiemetic interventions, and methodological issues. Acta Anaesthesiol Scand. 2001;45(1):4–13.

    Not in our library10.1034/j.1399-6576.2001.450102.x

  416. 416.

    Gan TJ Coop A Philip BK: A Randomized, Double-Blind Study of Granisetron Plus Dexamethasone Versus Ondansetron Plus Dexamethasone to Prevent Postoperative Nausea and Vomiting in Patients Undergoing Abdominal Hysterectomy. Anesth Analg. 2005;101(5):1323–9.

    Not in our library10.1213/01.ane.0000180366.65267.f6

  417. 417.

    White PF Watcha MF: Postoperative Nausea and Vomiting: Prophylaxis Versus Treatment. Anesth Analg. 1999;89(6):1337.

    Not in our library10.1097/00000539-199912000-00001

  418. 418.

    Gillmann HJ Wasilenko S Züger J: Standardised electronic algorithms for monitoring prophylaxis of postoperative nausea and vomiting. Arch Med Sci. 2019;15(2):408–15.

    Not in our library10.5114/aoms.2019.83293

  419. 419.

    Habib AS Reuveni J Taguchi A: A comparison of ondansetron with promethazine for treating postoperative nausea and vomiting in patients who received prophylaxis with ondansetron: A retrospective database analysis. Anesth Analg. 2007;104(3):548–51.

    Not in our library10.1213/01.ane.0000252433.73485.be

  420. 420.

    Habib AS Gan TJ: The effectiveness of rescue antiemetics after failure of prophylaxis with ondansetron or droperidol: A preliminary report. J Clin Anesth. 2005;17(1):62–5.

    Not in our library10.1016/j.jclinane.2004.04.004

  421. 421.

    Brookes CD Berry J Rich J: Multimodal protocol reduces postoperative nausea and vomiting in patients undergoing Le Fort I osteotomy. J Oral Maxillofac Surg. 2015;73(3):324–32.

    Not in our library10.1016/j.joms.2014.08.007

  422. 422.

    Mayeur C Robin E Kipnis E: Impact of a prophylactic strategy on the incidence of nausea and vomiting after general surgery. Ann Fr Anesth Reanim. 2012;31(2):e53–e57.

    Not in our library10.1016/j.annfar.2011.10.016

  423. 423.

    Myklejord DJ Yao L Liang H: Consensus guideline adoption for managing postoperative nausea and vomiting. WMJ. 2012;111(5):207–13; quiz 214.

    Not in our library

  424. 424.

    Yazbeck-Karam VG Siddik-Sayyid SM Barakat HB: Haloperidol Versus Ondansetron for Treatment of Established Nausea and Vomiting Following General Anesthesia: A Randomized Clinical Trial. Anesth Analg. 2017;124(2):438–44.

    Not in our library10.1213/ane.0000000000001723

  425. 425.

    Hu X Fang T Gong L: Higher dose of palonosetron versus lower dose of palonosetron plus droperidol to prevent postoperative nausea and vomiting after eye enucleation and orbital hydroxyapatite implant surgery: A randomized, double-blind trial. Drug Des Devel Ther. 2017;11:1465–72.

    Not in our library10.2147/dddt.s129022

  426. 426.

    Rüsch D Eberhart LHJ Wallenborn J: Nausea and vomiting after surgery under general anesthesia: An evidence-based review concerning risk assessment, prevention, and treatment. Dtsch Arztebl Int. 2010;107(42):733–41.

    Not in our library10.3238/arztebl.2010.0733

  427. 427.

    Rüsch D Arndt C Martin H: The addition of dexamethasone to dolasetron or haloperidol for treatment of established postoperative nausea and vomiting. Anaesthesia. 2007;62(8):810–7.

    Not in our library10.1111/j.1365-2044.2007.05136.x

  428. 428.

    Therneau IW Martin EE Sprung J: The Role of Aprepitant in Prevention of Postoperative Nausea and Vomiting After Bariatric Surgery. Obes Surg. 2018;28(1):37–43.

    Not in our library10.1007/s11695-017-2797-0

  429. 429.

    Trimas SJ Trimas MD: Use of Aprepitant and Factors Associated With Incidence of Postoperative Nausea and Vomiting in Patients Undergoing Facial Plastic Surgery. JAMA Facial Plast Surg. 2015;17(4):251–5.

    Not in our library10.1001/jamafacial.2015.0307

  430. 430.

    Thomas JS Maple IK Norcross W: Preoperative Risk Assessment to Guide Prophylaxis and Reduce the Incidence of Postoperative Nausea and Vomiting. J Perianesth Nurs. 2019;34(1):74–85.

    Not in our library10.1016/j.jopan.2018.02.007

  431. 431.

    Fearon JA Dimas V Ditthakasem K: A Randomized Controlled Trial of Oral Versus Intravenous Administration of a Nonnarcotic Analgesia Protocol Following Pediatric Craniosynostosis Corrections on Nausea and Vomiting Rates. J Craniofac Surg. 2015;26(6):1951–3.

    Not in our library10.1097/scs.0000000000002009

  432. 432.

    White PF: What are the advantages of non-opioid analgesic techniques in the management of acute and chronic pain? Expert Opin Pharmacother. 2017;18(4):329–33.

    Not in our library10.1080/14656566.2017.1289176

  433. 433.

    Gärtner R Kroman N Callesen T: Multimodal prevention of pain, nausea and vomiting after breast cancer surgery. Minerva Anestesiol. 2010;76(10):805–13.

    Not in our library

  434. 434.

    Tan M Law LSC Gan TJ: Optimizing pain management to facilitate Enhanced Recovery After Surgery pathways. Can J Anaesth. 2015;62(2):203–18.

    Not in our library10.1007/s12630-014-0275-x

  435. 435.

    Azhar RA Bochner B Catto J: Enhanced Recovery after Urological Surgery: A Contemporary Systematic Review of Outcomes, Key Elements, and Research Needs. Eur Urol. 2016;70(1):176–87.

    Not in our library10.1016/j.eururo.2016.02.051

  436. 436.

    Ziemann-Gimmel P Goldfarb AA Koppman J: Opioid-free total intravenous anaesthesia reduces postoperative nausea and vomiting in bariatric surgery beyond triple prophylaxis. Br J Anaesth. 2014;112(5):906–11.

    Not in our library10.1093/bja/aet551

  437. 437.

    Peyton PJ Wu CY: Nitrous Oxide-related Postoperative Nausea and Vomiting Depends on Duration of Exposure. Anesthesiology. 2014;120(5):1137–45.

    Not in our library10.1097/aln.0000000000000122

  438. 438.

    Myles PS Chan MTV Kasza J: Severe Nausea and Vomiting in the Evaluation of Nitrous Oxide in the Gas Mixture for Anesthesia II Trial. Anesthesiology. 2016;124(5):1032–40.

    Not in our library10.1097/aln.0000000000001057

  439. 439.

    Janhunen L Tammisto T: Postoperative vomiting after different modes of general anaesthesia. Ann Chir Gynaecol Fenn. 1972;61(3):152–9.

    Not in our library

  440. 440.

    Cheng CR Sessler DI Apfel CC: Does Neostigmine Administration Produce a Clinically Important Increase in Postoperative Nausea and Vomiting? Anesth Analg. 2005;101(5):1349–55.

    Not in our library10.1213/01.ane.0000180992.76743.c9

  441. 441.

    Lee OH Choi GJ Kang H: Effects of sugammadex vs. pyridostigmine-glycopyrrolate on post-operative nausea and vomiting: Propensity score matching. Acta Anaesthesiol Scand. 2017;61(1):39–45.

    Not in our library10.1111/aas.12813

  442. 442.

    Yağan O Taş N Mutlu T: Comparison of the effects of sugammadex and neostigmine on postoperative nausea and vomiting. Braz J Anesthesiol. 2017;67(2):147–52.

    Not in our library10.1016/j.bjane.2015.08.003

  443. 443.

    Tas Tuna A Palabiyik O: Does Sugammadex Administration Affect Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy: A Prospective, Double-Blind, Randomized Study. Surg Laparosc Endosc Percutan Tech. 2017;27(4):237–40.

    Not in our library10.1097/sle.0000000000000439

  444. 444.

    Manahan MA Johnson DJ Gutowski KA: Postoperative Nausea and Vomiting with Plastic Surgery: A Practical Advisory to Etiology, Impact, and Treatment. Plast Reconstr Surg. 2018;141(1):214–22.

    Not in our library10.1097/prs.0000000000003924

Cited by papers we hold 1

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.